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Introduction
Soon after the introduction of transplantation it was realized that not every
donor organ was suitable for any recipient and an allocation process was
devised, initially in individual transplant centers and then on a national and
international basis.
Donor organs must be allocated to the best possible recipients, who may be
stratified according to numerous demographic and immunological factors,
such as age, gender, clinical diagnosis, urgency, time on the waiting list,
transplantation center, number of previous transplantations, ABO blood
group, HLA types, and presence of anti-HLA antibodies.
HLA-matching is one of the constraints on the allocation process. The large
number of antigens in the HLA-A, B, and DR loci makes it highly unlikely that,
without prospective HLA-matching, a single donor organ will be completely
compatible with a particular recipient. The use of immunosuppressive therapy
has made it possible to reduce the adverse effects of HLA mismatches. Also,
the chance of finding an acceptable match is increased considerably if the
size of the pool of potential recipients is large. This consideration was the
motivation for the creation in 1967 of Eurotransplant (Leiden, the Nether-
lands), the first multinational organ-exchange organization (OEO) [1]. The
Eurotransplant concept has since been emulated in several other countries.
Table 1. Eurotransplant involvement
In:
Kidneys
Corneas
Livers
Pancreas
Hearts
Heart/lung
Tissues
Lungs
Since:
1967
1976
1979
1981
1982
1984
1986
1987
Over the years, OEOs have become involved not only in renal transplantation
but also in the transplantation of other solid organs, such as heart, lung, liver,
and pancreas [table 1 ]. They were instrumental in the establishment of a more
structured network in which donor hospitals, transplant programs, and tissue-
typing laboratories could work together. They were able to apply the technical
and administrative infrastructures developed for kidney transplantation to the
transplant of other organs. However, HLA-matching does not provide the
same beneficial effect on graft and patient survival that is seen with kidney
transplants. Therefore, organ-specific allocation rules were devised at Euro-
transplant, where they are regulated by organ-specific advisory committees
[figure 1].
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Figure 1
When transplantation was first introduced as a new therapy for end-stage
organ failure, the number of patients on the waiting list and the number of
available donors was understandably small. The acceptance of transplanta-
tion by both the medical profession and patients as the treatment of choice, in
conjunction with the education of patients and the community as a whole, has
led to an increase in the number of patients requiring transplant as well as the
number of donors. Unfortunately, the number of patients continues to grow
more rapidly than the number of donors. For example, in 1979 there were 1929
patients on the Eurotransplant kidney waiting list but only 1050 kidney
transplantations were performed. These numbers increased to 7765 and
3048, respectively, in 1989 and to 12305 and 3050 in 1999. Thus, the size of
the waiting list increased six-fold in two decades while the number of trans-
plantations increased only three-fold. Transplantation became a victim of its
own success [2].
The almost exponential growth of waiting lists, which illustrates the magnitude
of the donor-organ shortage, has resulted in an increased interest in the
transplantation field among governments, the media, and the general public.
Public debates have led to new legislation in several countries and some
countries now use the rule of 'presumed consent' in which individuals are
considered as potential donors unless they have stated otherwise, while
others follow the rule of 'informed consent'.
Bodies such as the Council of Europe and the European Union can do little to
22 Chapter 1
alleviate the organ-donor shortage or unify legislation. The Council of Europe
can only make recommendations to its member states and the European
Union has questionable jurisdiction in the field of healthcare. For example,
despite recent European Court of Justice decisions in the Kohll and Decker
cases [3], Eurotransplant continues to enforce a strict non-resident policy [4].
Moreover, the fundamental principle of free movement within Europe is in
contrast to the basic Eurotransplant principle that allows organ allocation
within the same region or country before organs are offered to other member
states, a principle designed to maintain an import-export balance. Solidarity
between Eurotransplant member countries is one of the basic principles of the
organization and one that is emphasized in the document on Eurotransplant
recently ratified by the Ministers of Health from the six member countries [5].
The high level of international cooperation in the field of organ transplantation
is also emphasized by the recent enactment by Germany of a treaty that
designates Eurotransplant as the allocation agency for all donor organs in that
country. Eurotransplant therefore now maintains a unified patient waiting list
for all solid organs. Using the donor's medical data, Eurotransplant prepares
a shortlist of suitable recipients. All organs transplanted in Germany, regard-
less of their country of origin, must be provided through Eurotransplant
according to the provisions of the treaty.
The reduction in the number of road traffic accidents and improvements in
intensive-care facilities have contributed to a decrease in the number of
deaths among young people and consequently to a decline in the number of
high-quality organs available for transplant. Cadaveric donors still provide the
majority of donated organs but, in Eurotransplant in 1999, living-related
donors provided 579 kidneys and 64 liver segments for their relatives' trans-
plants. The ethics of such donations are more complex than those for
unrelated cadaveric donations because the question of consent is inevitably
confounded by the emotional involvement of donors and their related patients.
More recent additions to the class of living donors are cross-related donations
and altruistic donations from individuals not genetically or emotionally related
to the recipients.
Increasing the number of cadaveric donors through effective donation
schemes is one way to increase the supply of donated organs. Better
communication between the medical profession and the relatives of potential
donors, as well as improved awareness of organ donation among medical
professionals play an important part in these schemes. Another way to
improve donation is to improve the efficiency of organ procurement proce-
dures by using more than one organ from each donor. There are very few
arguments against such measures. However, the use of organs from donors
older than 65 years of age, very young donors or living donors presents more
serious ethical dilemmas, as do other methods to increase donation rates,
such as the use of non-heart beating donors [6], /n s/ftv kidney cooling prior to
organ donation, and remuneration for funeral costs and/or organ donation.
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The potential use of organs from animals (xenotransplantation) not only raises
the question of animal rights but also confronts society with the possibility of
introducing foreign animal viruses and other pathogens into humans. Also, the
formidable barrier of acute rejection of such transplants must be resolved.
Recently, the British Government announced that it would take advice from a
commission led by its chief medical officer to permit the cloning of human cells
for 'therapeutic' purposes such as transplantation research and studies of the
mechanisms of disease aetiology. In this procedure, the cell nucleus is
removed and inserted into an egg whose own nucleus and genetic information
has been removed. Stem cells, the precursors of organs and tissues, could be
isolated and removed later from the resulting embryos. Those cells could then
be cultured to provide the desired organs and tissues. Although the British
Government emphasized that strict controls would be applied to such
research, the announcement of its plan is certain to generate a considerable
public debate over the ethical aspects of the proposal, even before it is
considered by Parliament.
Allocation systems have evolved to make organ allocation procedures as
transparent and flexible as possible. However, such systems are rarely
clearcut and a completely fair system might not be attainable. Moreover, as
Rudge emphasizes in his review of the ethics of organ donation, most
clinicians would advocate an allocation system that takes clinical need into
account as well as, for example, HLA status, time on the waiting list, and so
on [7],
The admission of patients to waiting lists and the criteria used to allocate donor
organs also raise other ethical questions. Most allocation algorithms favor the
very young and clinically high-urgent patients. Such issues demonstrate the
tension between the desire of the medical profession to provide the best
possible care for each individual patient in a just manner, a duty-based
approach, and the desire to provide the greatest good to the greatest number
of people-utilitarianism.
In today's world of limited financial resources and increasing healthcare
rationing, utilitarianism might have the upper hand, but no one approach is
able to provide all the answers. They do, however, help the transplant
community structure the debate on the problem and to draw up guidelines and
legislation to govern the allocation of organs. Moreover, as transplantation
technology evolves, the associated ethical dilemmas faced by medical profes-
sionals, the general public, and patients will also change. For example, now
that xenotransplantation is recognized as a real possibility for relieving the
shortage of donor organs, questions of animal exploitation and the accepta-
bility of animal organs are raised. Similar questions will arise with each new
development and the guidelines and legislation policies governing the field of
transplantation must be regularly updated to take each new development into
account.
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Aim of the thesis
The aim of this thesis is to survey current donation, procurement, and
allocation trends in transplant programs across the world, but especially in
Europe. The purpose of the survey is to provide a basis on which to judge some
of the ethical dilemmas associated with transplantation and their influence on
donation rates and European transplant legislation. These are discussed in
chapter 2. Literature searches, including a brief review of some of the
influential transplantation stories reported in the media, form the basis of
chapter 3, which assesses current attitudes to organ donation, procurement,
and transplantation. Data from OEOs, such as Eurotransplant, are analyzed
in chapter 4, which provides a picture of the scale of the current shortage of
donor organs. Chapter 5 focuses on recenttrends in organ donation, including
developments in living related and unrelated donation in different parts of the
world. In chapter 6, potential solutions to the organ donor shortage crisis are
assessed. The development of a special program called the European Donor
Hospital Education Programme (EDHEP), which was created to meet the
widely perceived need to help doctors and nurses feel effective in dealing with
the bereaved and in requesting organ donation, is described in chapter 7. In
chapter 8, the Donor Action Programme, a quality assurance initiative specif-
ically aimed to raising donation rates in intensive care units, is described.
Finally, in chapter 9, new approaches to alleviate organ shortages are
discussed, in particular the use of kidneys from elderly donors, an option that
is currently being explored and one that could serve as an example of how to
increase organ availability.
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Introduction
In 1841, the American sailing ship William Brown, while en route from
Liverpool to Philadelphia, drifted onto an iceberg just off the coast of New-
foundland. Its single lifeboat offered a very small chance of survival. It leaked
and soon filled up with far more passengers than it could safely hold. Although
the passengers worked throughout the night with buckets and pumps, the
seawater continued to rise. By the light of dawn one thing was clear to
everyone: unless the number of passengers was reduced by at least half,
everyone would soon drown. Eventually, after some hesitation, the coxswain,
in desperation, ordered the sailors to throw 14 passengers overboard to their
certain deaths in the ice-cold sea, to the horror of the other passengers.
One hundred and fifty years later, we are faced with a similar ethical dilemma
that is also related to a life-saving procedure, namely, organ transplantation.
This ethical dilemma is unique in the annals of medical science since it is
related not to the performance of a medical procedure per se but to the
overwhelming success of the procedure.
Ethical constraints are inevitably linked to organ donation and transplantation.
These activities are subject to regular and fairly penetrating attention from the
media. The issues receiving attention are almost always closely linked to their
ethical aspects, e.g., setting a maximum age for potential organ recipients or
legislative constraints on a particular aspect of organ transplantation.
Continual developments in the field of organ transplantation, i.e., immunosup-
pressive therapy and organ preservation, leading to the ever-increasing
success of, and possibilities for, transplantation, have led to an ever-increas-
ing demand for donor organs. Unfortunately these increases have not been
followed by similar increases in the number of organ donors. The conse-
quence of this shortage is that many patients remain on waiting lists for
transplantation for months or even years and, tragically, too many of them die
while waiting. This situation leads to enormous ethical dilemmas: how to
distribute the available organs, what methods to use to reduce the donor
shortage and, finally, how to prevent the development of commercial trade in
organs encouraged by this donor shortage. For whenever there is a distorted
supply-demand ration, there are always people who cleverly manage to use
the situation to their own commercial advantage.
In the United States, it has been suggested that the next of kin be paid a sum
of money to cover funeral costs if they agree to organ donation [11], the
underlying motive being, of course, to persuade people to allow their relatives'
organs to be removed and used for transplantation purposes. This idea is,
however, not really new. Funeral costs have long been covered in cases where
a body has been made available for medical research purposes. However, the
consequence of such measures will surely be that people in a financially weak
position will agree to organ donation not for humanitarian but for financial
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reasons. It is, indeed, questionable as to whether this is the proper way to
solve the great organ shortage. In any case, it is highly unlikely that a solution
will be found in the near future. The discrepancy between supply and demand
will continue to leave its mark on the distribution of organs among the
increasing number of potential recipients.
In December 1990, a conference was held in Munich, Germany, on ethics,
justice and commerce in organ replacement therapy. The problems that were
addressed at that meeting still confront us. For that reason, we have decided
to address some of them in the context of present-day conditions.
Allocation
The continuing shortage of donor organs confronts us with one of the greatest
problems related to organ transplantation: allocation. Who decides which
patient gets the available organ? Most people agree that doctors should
decide, their argument being that, on the basis of medical criteria, doctors are
in the best position to determine which organ should be allocated to which
patient. This is, however, only partly true, for if, for example, one heart is
available, there are almost always several patients on the current waiting list
who can all be shown to qualify equally and simultaneously for that one heart.
Which patient should then be chosen, and what criteria should be used to
make this decision? Can such a decision be made purely on the basis of
medical criteria? What other factors should be taken into account? The core
principle of the Hippocratic tradition commits the physician to place the health
of his patient as his first moral priority, but this principle is inadequate when it
comes to transplantation.
The distribution of organs does not depend solely on medical factors. Many
non-medical factors also play an important role, such as equal opportunities,
compassion, justice, etc. Medical criteria must be considered in combination
with non-medical ones. Obviously, a doctor will tend to seek what is best for
his own patient, and this could lead to an unfair or incorrect organ distribution
that would adversely affect other patients. Would it not be more fitting, from an
ethical point of view, if all members of society were involved in this discussion
instead of leaving the decisions solely in the hands of the medical profession?
Even if this were the case, which criteria should be considered when allocating
an organ? The choice is, indeed, a difficult one. The following four approaches
have been suggested:
1. The "life-saving principle": the organ is given to the person who needs it the
most urgently. This is a purely medical decision where patients in the
poorest state of health have the highest priority.
2. "First come, first served": the organ is allocated to the recipient who has
been waiting the longest. This would appear to be the fairest way.
3. Optimal usage of the donor organ: priority is given to the patient whose
transplantation is expected to be the most successful.
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4. A random lottery: a lottery is held in which the medical and psycho-social
status of the recipient is not considered at all. Such a practice is seldom
applied and would certainly not be popular in the medical community.
Generally speaking, organ allocation takes place on three different levels.
Firstly, there are the doctors and their patients. The doctors want their patients
to get better as quickly as possible and, therefore, want to give them an organ
that will save their lives or improve their quality of life. Secondly, there are the
various transplantation centers which, although they are partners when it
comes to the transfer of knowledge, become rivals when it comes to competing
for available organs. And thirdly, there is the responsibility of politicians, e.g.,
with regard to determining a maximum age for potential transplant recipients or
designating the maximum number of centers for transplantation. On a political
level, decisions are often subject to budgetary constraints, which compounds
the difficulty of allocation. Since this sometimes has direct consequences for a
large group of people, it is likely to be influenced by public opinion.
The interest groups directly affected (i.e., potential transplant recipients and
their families) naturally want to influence the distribution policies for donor
organs. This clearly does not make it any easier for those directly involved in
the organ allocation process. The system of organ allocation differs greatly
from one type of donor organ to another. For donor kidneys, one is confronted
with the "conflict of interests" faced by dialysis doctors [14]. On the one hand,
they want to encourage transplants for their kidney patients undergoing
dialysis but, on the other hand, this then leads to a loss of income for them.
Looking in particular at private dialysis centers, there is clear evidence that
proportionally fewer patients from these centers are referred for transplanta-
tion than from public hospital centers. After all, the fewer patients there are
undergoing dialysis, the less income there is for the center's medical and other
personnel [12,19].
The allocation problem for patients waiting for a heart transplant is completely
different. In practice, patients referred for a heart transplant often die while on
the waiting list, due to the shortage of donors. This is closely linked with the
ethical problem that a patient with a good chance of being cured may die while
on the waiting list because, at present, organs are often assigned to the
clinically more urgent patient whose condition is unstable and who is, there-
fore, clearly less likely to survive while on the waiting list [13]. The develop-
ment of mechanical support devices now makes it possible for some of these
patients to survive while waiting for a transplant. Although the transplantation
results were initially disappointing for these patients, their results are now
improving [1]. An organ is found in time for just over half of this category of
patients; yet, of these patients, less than half leave the hospital alive following
transplantation. The poor medical status of these patients is thought to be the
main contributing cause of failure of these transplants. This situation has led
some of the medical specialists involved to increasingly wonder whether it
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would not be more responsible to implant the available donor hearts in patients
with the best chance of survival.
The allocation of donor livers raises ethical problems that are similar to those
encountered in heart transplantation. Here, too, the question arises as to who
should receive an available liver: the patient who has been waiting the longest,
the patient who has the best chance of success, or the patient with the most
urgent need? Difficult questions like this are the order of the day. Imagine, for
example, that there is a good donor liver available. Who is the most eligible
candidate for the liver: the younger patient who urgently needs a liver due to
acute fulminant hepatitis and who has good prospects for a healthy life
following liver transplantation or an older patient with carcinoma of the liver,
knowing that the results of liver transplantation in the latter case are often
disappointing? Should we conclude that it is wiser from an ethical point of view
to make the liver available to the recipient with the greatest chance of
success? Is it ethically correct to make such a decision and to argue that if a
liver or a heart transplant has a high chance of failure the organ should not be
made available to that recipient? Or should the most urgent patient be entitled
to the organ because the less urgent patient has the change of another offer
in the future? Who should have to make such decisions over the life and death
of a fellow human being?
Living related transplantation
Transplanting a kidney from a patient's relative often provides an alternative
to having to wait a long time for a suitable donor kidney. However, such
donations are ethically acceptable only if both the recipient and the donor are
well informed and have voluntarily made a conscious decision. In addition to
reducing the waiting period, living related transplantation had advantages
from an immunological point of view, since there is often a large degree of
similarity between the tissue types of the donor and the recipient. The small
risk of rejection leads to a larger chance of a successful transplant [9], Ethical
considerations regarding living related transplantation include, among other
things, the question of whether it is right to deliberately harm one person in
order to help another. In order to answer this question, it is necessary to
balance the risk to the donor against the benefit for the recipient, whereby it
should be emphasized once more that donation as an option is only consid-
ered on the basis of voluntarism and full information, "informed consent".
Many years of experience in kidney transplantation using related donor
kidneys makes it evident that the quality of life of such kidney transplant
recipients is greatly superior to that of dialysis patients and that the risk to the
donors is almost non-existent. In other forms of organ transplantation, this
risk-benefit consideration needs to be examined from a completely different
angle. Due to the shortage of organs, over the last few years research has
been carried out, mainly in the United States, into living related transplantation
with a section of liver, pancreas, lung, or small bowel The distinctive feature
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here is that this method uses a portion of organs that still retain their function
in the donor after partial resection. The risks to the donor from such donations
are obviously far greater that the risks involved in a kidney donation. In
Chicago, a study on partial liver transplantation has been conducted, inspired
by a chronic shortage of livers, especially for small children [22]. More than 20
small children have been transplanted -almost all successfully- with the partial
liver sample from a relative. The following prerequisites have been set for this
type of liver donation:
1. The liver transplantation must have a good chance of success.
2. The risk to the donor must be minimal.
3. The donation should be voluntary.
In the case of liver donation by a relative, the concept of voluntarism in
particular raises a number of questions. How voluntary is this donation when
it concerns the life or death of your own child? In contrast to kidney donation,
where the alternative is dialysis, in the case of a liver transplant the life of the
young liver patient is at stake, and parents are under enormous emotional
pressure when making a decision on liver donation. This pressure on the donor
is made even greater by the fact that the partial removal of the liver carries far
greater risks to the donor than the removal of a kidney, to what extent can we
legitimately speak of a donation that is ethically sound on the strength of these
risk-benefit considerations?
Currently, living related transplantation with a section of the liver is mainly
being carried out in a few centers in Europe, Japan and the United States, but
with the long waiting lists and the shortage of donor livers, it is probably only
a matter of time before the discussion on living related liver transplantation by
partial resection finds its way to other parts of the world. Would it not be better
to increase the opportunities for postmortem organ donation so that donations
by members of the family are no longer necessary?
Another form of living related donation involves a section of the pancreas
(usually in combination with one kidney). Unlike kidney transplantation,
pancreas transplantation per se does not save lives, but it does contribute to
a better quality of life for the diabetic patient. Research has shown that the best
results are obtained in cases of combined kidney/pancreas transplants
[8,10,17,18].The prerequisites are similar to those for living related kidney
transplantation, namely, a close immunological match between donor and
recipient. However, in closely related donor-recipient pairs like identical twins
and HLA-identical siblings, graft failure caused by the recurrence of diabetes
has been observed when no or low-dose immunosuppression protocols have
been used [16]. The advantage of a shorter waiting period does not apply to
living related pancreas transplantation as it does to kidney transplantation, as
there is currently no real shortage of pancreases. The fact that not all of the
pancreases available from organ donors are actually used for transplantation
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is more a problem of logistics than of immunology. The argument for pancreas
transplantation is that the mortality rate of diabetics undergoing conventional
insulin treatment is considerably higher than the mortality rate after a success-
ful pancreas transplantation. The argument against living related pancreas
transplantation is the fact that it remains a major surgical procedure and, as
such, poses an increased risk of postoperative mortality to the donor. The
long-term results of living related pancreas transplantation cannot yet be
determined as our experience with it is still too limited.
Research is also being done on a much smaller scale into living related
donation ofa section of the lung [15]. A small number of partial lung transplants
from parent to child have been performed. An even smaller number of
transplants with a section of the small bowel have also taken place [2]. This
form of transplantation is the only hope for patients with the small bowel
syndrom, an illness that causes massive deterioration of the small bowel. Both
the partial lung transplants and the partial small bowel transplants are still in
too much of an experimental stage to enable one to draw any conclusions
about their efficacy.
Future prospects
As if the ethical questions already posed were not enough, we would like to
take a brief look into the future. What can we expect?
In worldwide attempts to find a solution for the shortage of donor organs, other
donor sources and new transplantation methods are being explored. Although
the possibility of using so-called non-heart beating donors was introduced as
long ago as 1980, that policy has not received the attention it deserves [4,20],
Non-heart beating donors are those whose cause of death is failure of their
cardiopulmonary systems rather than brain death. The results of short and
long-term studies on the survival of grafts obtained from these donors have
shown a high degree of similarity with those obtained from heartbeating
donors [21].
Research is currently being done into the possibility of cell transplantation with
isolated cells from fetal tissue [5,7]. The results to date are disappointing. The
use of fetal tissue for transplantation raises several ethical questions, such as:
1. What is the position of the pregnant woman?
2. Who gives permission for the use of fetal tissue? Is it the woman?
3. Does the woman have a say in the choice of the recipient?
It seems that, for the moment, the use of fetal tissue should be permissible
where it has been shown to be effective, provided certain rules are applied to
prevent improper use (such as commercial use or elective abortion).
Research has also been carried out for many years on the use of animal
organs (e.g., from pigs and monkeys) for transplantation purposes, so-called
xenotransplantation [3]. The idea here is to implant animal organs in order to
keep patients alive until a suitable human organ has been found or, perhaps,
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in the future even to use these organs for long-term therapy. From an ethical
point of view, however, the relationship between man and beast forms a central
theme in the discussion over whether the transplantation of animal organs can
be reconciled with our moral feelings. The central question here is, what
position does man occupy in the hierarchy of living creatures? It seems
realistic to assume that most humans would ascribe a lower position to animals
than to humans. However, this value judgment does not imply that we should
allow animals to suffer unnecessarily or that we should use them without
restriction for the sake of our won health. In view of the growing awareness and
reverence for nature and the environment, it would be wise from a moral point
of view to only use animals as "organ suppliers" when there is absolutely no
other alternative for saving human lives.
Conclusion
The argument that every patient should wait his or her turn according to a
random lottery is not without a legal precedent. After the lifeboat from the
William Brown had reached the coast safely, a man named Holmes, who was
one of the crewmen, was arrested, tied and convicted of murder. The judge
decreed that the passengers should have been spared at the expense of the
non-essential crewmen. If that was not possible, the passengers should have
been able to select their own victims by means of a lottery. The Court of Justice
decided that, under the circumstances, a lottery would have been the only
morally acceptable selection process.
A more contemporary view was reached at the conclusion of a joint meeting
of the European Society for Organ Transplantation (ESOT) and the European
Dialysis and Transplant Association/European Renal Association (EDTA/
ERA) in Munich in December of 1990. One of the resolutions accepted by the
participants was that "cadaveric organs procured within a community should
be considered as assets of the community, and the community rather than just
the medical profession should determine their allocation through announced
criteria" [6].
Finally, it is encouraging to note that, recently, the Euro-Parliament, the
Council of Europe, and the French Parliament have all addressed the ethical
aspects of organ procurement and transplantation.
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Introduction
Advertisements offering to buy or sell organs for transplantation appear in
most countries, although they are most common in the developing world.
Some of the desperate requests from patients themselves or the parents of
children with end-stage renal disease evoke readers' sympathy, while the
avarice exhibited in others is disturbing.
Most people consider such commerce in transplant organs abhorrent and
demand its prohibition. However, the term commerce is not usually defined.
According to Tfte A/ew Shorter Oxford £ng//s/7 D/cf/ona/y, commerce is the
exchange of merchandise and, in Weösfer's D/cf/onary, it is the interchange of
goods, wares, productions, or property of any kind, between nations or
individuals, either by barter, or by purchase and sale, trade, or traffic. Whether
or not the opponents of commerce in transplant organs are against all forms
of commerce is unclear.
However, what is implicit is the concept of a tough private market in which a
donor sells an organ to a recipient for a price, paid either directly to the donor
or to an intermediary. If private-fee enterprise markets were feasible then their
distribution practices would be clear, at least on the demand side, and organs
would go only to those with the ability to pay.
The allocation of organs based on ability to pay obviously violates the
egalitarian ethic of distributive justice embodied in the legislation of most
western countries. Furthermore, if life-saving organs were to be distributed on
an ability to pay basis, thereby favoring the wealthy, any prospect of increasing
the volume of voluntary organ donations would be seriously jeopardized.
In this article, we look at examples of commerce in organ transplantation, in
particular the so-called organ trafficking story that first appeared in 1987. Pub-
lication of this report has had a great impact on the development of legislation in
Europe in the past 10 years. We also address some more recent reports of
commerce in transplantation and illustrate how they effect policy making.
The organ trafficking story: kidnapped babies provide donor organs
Rumors about the existence of child trafficking to satisfy the demand for donor
transplant organs first began to circulate in Latin America in 1987. However,
little or no documentary evidence was found to support these claims. Locating
eyewitnesses to the events proved difficult, if not impossible, information was
inconsistent, and the names and identities of the presumed victims were
difficult to trace. Consequently, most of the accounts could not be confirmed
and were concluded to be simply rumor [1-4], Indeed, at a press conference
on January 8, 1987, a senior official of the Honduran Committee of Social
Welfare categorically denied reports of trafficking in babies to supply organs
for transplantation. Nevertheless, the rumors continued and eventually the
story appeared in Europe [3,5].
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European political consequences
On May 5, 1987, an Italian member of the European Parliament tabled a
motion on the issue that asked if the European Commission had any knowl-
edge of children from Honduras and other Latin American countries serving as
sources of replacement organs in Europe. The reply was: 'The commission
does not know of any transplant operations performed in Europe for which the
organs of Latin American children have been used. The adoption described by
the honorable members would be strictly forbidden in the Community under
the laws on adoption in the member states.'
On November 16-17, 1987, a Conference of European Health Ministers was
convened in Paris under the auspices of the Council of Europe. The final text
agreed by the Ministers includes the following paragraphs on the non-
commercialization of human organs: 'A human organ must not be offered for
profit by any organ-exchange organization, organ-banking center or by any
other organization or individual whatsoever... Neither organizations nor
individuals should advertise outside their national territory either for donation
or transplantation' [6].
Despite the denials of the 'baby parts' story and the recommendations of the
health ministers, the story continued to circulate and comments continued to
be made [3]. For example, in the spring of 1993, a French European Parlia-
ment member published a report on the Pron/b/f/on of fne frade of organs for
fransp/anf based on circumstantial evidence and rumored stories [7]. The
report called for the European Council of Ministers to take the necessary
measures to ban the trade in organs for profit throughout the European Union
(EU), including a ban on all organ import transactions in which the origin of the
organ, the voluntary nature of the donation, or the anonymity of the donor with
respect to the recipient were uncertain. In addition, the report recommended
that members of surgical teams carrying out transplants should be approved
and monitored by a supervised body, and that organs should not be removed
from minors except in exceptional cases. A legislative code of conduct was
also recommended. While such measures seem logical, the publication of this
report, once again, damaged transplantation while the story continued to
make good copy.
Media consequences
Later in 1993, television documentaries - a joint British-Canadian production
called Tne body parts bus/ness, an independent French film entitled Tne organ
fn/eves and a BBC Everyman documentary - broadcast the 'baby-parts'
stories, thus adding credibility to the myth. These programs contained dramat-
ic charges by Latin American 'victims'and their families, who claimed that their
corneas had been stolen while they had been in hospital for other reasons.
However, when officials investigated the charges, they discovered that the so-
called victims had lost their sight following infections that had occurred years
before.
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These documentaries also revealed serious irregularities in Russia in the way
brain death was determined in organ donors. In a number of cases, organs
were removed from patients who were technically and, perhaps, legally alive.
Although the sale of human tissues is illegal in Russia, the TV investigators
found a company which, in one year, claimed to have extracted many tissues,
including 8000 thymuses, 2000 eyes, and more than 3000 pairs of testicles.
These tissues were available for sale in any part of the world for use in
pharmaceutical, cosmetic or surgical procedures. Trafficking of this kind has
never been officially denied by the Russian Government.
Clearly, program makers, the transplant community, and governments need to
ensure that a clear distinction is made between the facts behind such stories,
which must be backed up by solid evidence, and the rumors and stories
contrived by journalists on slow news days. In addition, clear communication
of the facts is also important as many issues in transplant medicine confuse
both the media and the public, such as cadaveric versus living donation and
organ versus tissue donation. Such confusion may lead to misunderstanding
and a reluctance to donate organs and tissues by the general public.
Transplant tourism: registration on multiple European waiting lists
As the shortage of organs persists, a phenomenon known as 'transplant
tourism' has emerged. Transplant tourists are patients who travel to countries
where organs are available. They receive transplants either through registra-
tion on established transplant programs in Europe or the USA or through the
purchase of an organ from a living unrelated donor. The latter will not be
discussed further as there is no evidence that buying and selling of organs
from living donors occurs in Europe.
The registration of so-called non-resident patients on multiple waiting lists in
Europe is well-known, although the allocation of organs to this category of
patients differs widely between countries and centers. However, enabling non-
resident patients to register on waiting lists leads to unfair competition for local
patients and may falsely raise patients' hopes of a speedy transplantation. In
addition, it is likely that only affluent patients can afford to register on multiple
foreign waiting lists. Returning to the definition of commerce, it would also be
reasonable to question if the acceptance of non-resident patients on a routine
basis and on a large scale is entirely free of commerce. Perhaps this practice
does not benefit the individual physician, but the acceptance of non-resident
patients is certainly an incentive to the hospital, which is able to use its existing
infrastructure more effectively and reduce overhead costs.
Transplant tourism in Europe is difficult to control. Problems, such as the
prevention of multiple registrations on waiting lists of various European
transplant centers and European organ exchange organizations, have not
been solved, especially with respect to citizens of the European Union (EU).
Nevertheless, recent attempts have been undertaken to improve the control of
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the movement of patients from one country to another. For example, in 1996
the Board of Eurotransplant - the international organ-exchange organization
for the Netherlands, Germany, Belgium, Austria, and Luxemburg - issued
several guidelines that effectively reduced the number of non-resident pa-
tients on the Eurotransplant waiting list to a minimum [8]. Within Eurotrans-
plant, non-residents are patients not living in one of the countries participating
in the Eurotransplant organization. In the same year, similar guidelines for
Scandiatransplant were also confirmed by its member states [9].
In 1998, a Royal Decree was also published in Belgium that explicitly approved
the exclusion of non-residents from Belgian transplant waiting lists with the
aim of improving the chances of transplantation for Belgian citizens. Conse-
quently, the nationality and the residency of patients registered through a
Belgian transplant center must be carefully checked before the patient can be
put on the waiting list.
Recent developments
Since the Latin American story hit the headlines, transplant horror stories have
continued to appear. For example, recently, two Chinese men were arrested
for offering for sale organs and tissues from prisoners executed in China
[10,11]. The Chinese Government admits that organs are removed from
executed prisoners, but that it only happens rarely and with the prisoners
consent. Human rights campaigners, however, remain unconvinced [12].
Moreover, the EU has failed to support or introduce United Nations resolutions
on human rights in China that might stop this practice.
Meanwhile, in Israel, attempts to increase the supply of donor organs have led
to schemes in which organs are 'swapped' between suitable families [13,14].
The scheme enables a member of the family of a transplant recipient to donate
a kidney to a member of the donor's family. The Israel Health Ministry
regulates such transactions and ensures that no money changes hands
between families, although payments for expenses are allowed [13,15].
The Israeli Medical Association (IMA) regulates the conduct of transplant
surgeons and recently questioned a surgeon who allegedly transplanted
organs bought from Romanians into Israeli citizens [15]. The procedures took
place in Estonia and, therefore, were not regulated by Israeli law. Neverthe-
less, the IMA is clearly unsure about such behavior.
Strictly speaking, such transactions are covered by the definition of com-
merce; should they be banned along with those transactions in which money
changes hands?
Conclusion and suggestions
In many parts of the world, commerce in organ transplantation is rampant and
the various official pronouncements that international organizations have
made are not sufficient to combat such activities. Many tentative declarations
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of ethical principles have been made, but very few strategies for enforcing
them have received adequate attention. Perhaps it is time to make a shift from
making ethics declarations to the formulation of tough policies to prevent
unethical transactions in transplant organs. Recently, the Dutch Minister of
Health has taken the initiative to bring together colleagues from the countries
collaborating within Eurotransplant. The aim of this meeting is to investigate
possibilities to harmonize legislation in the Eurotransplant countries.
The fact that poor individuals are more likely than affluent people to sell their
organs is a highly visible sign of exploitation that has the potential to under-
mine the integrity of the entire transplant community. Whenever there is an
imbalance between supply and demand, the value of a scarce commodity
rises. Inevitably, affluent people will try to use their financial advantage to
acquire the organs or tissues they need while less fortunate patients remain
on waiting lists. Given western guidelines on organ distribution, ethical abuse
will most likely take place at the fringes, primarily in developing countries [16].
Medical and pharmaceutical institutions are, in general, in the best position to
detect and prevent unethical commercial practices and should remain alert. In
addition, the media may play an important role in detecting and reporting such
incidents in an objective manner.
In 1991, the World Health Organization (WHO) adopted the report
pr/nc/p/es on human organ fransp/anfaf/on' [17]. Although such initiatives
show a growing understanding of the urgency to establish international co-
operation and to introduce law enforcement, the fact of the matter remains that
guidelines are no more than recommendations and are therefore not legally
binding on the acceding states.
However, if set up, an International Donor Surveillance Committee could serve
as a central clearing house for information on malpractice in organ donation
and as an early warning system. Such a highly regarded authority could
regularly publish information on world commerce in organ donation and organ
trafficking - in a document similar to the Amnesty International annual report
on torture in the world - that would keep both the public and governments
informed of these abhorrent and unethical practices. In such a joint venture of
medical associations and human rights organizations, alleged incidents of
organ trafficking could be properly publicized and thoroughly investigated.
The importance of this proposal is illustrated in a very recent report of an arrest
in Rome of a US citizen. The man was advertising, via the Internet, human
organs for transplantation. He was enticed to Rome by transplant surgeons to
pick up payment for a graft and was arrested. No organs were used in Italy and
it is unclear who the donors were or where the organs came from. 'Whatever the
judicial outcome of this affair, transplantation experts in Italy are forecasting a
transient reduction in organ donations as often happens after shocking news of
human organ trafficking hits the headlines,' said the report of the arrest [18].
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Introduction
The Eurotransplant Foundation, founded in 1967, coordinates the matching
and exchange of donor organs across five European countries: Austria,
Belgium, Germany, Luxemburg, and the Netherlands. The primary goals of
Eurotransplant are: 1. to achieve an optimal use of available donor organs,
2. to secure a transparent and objective selection system based upon medical
criteria, and 3. to assess the importance of factors that have the greatest
influence on transplantation results [1]. These goals have changed very little
over the years; however, a fourth goal has recently been added: to support
donor procurement activities in order to increase the supply of donor organs.
This reflects Eurotransplant's concern with the chronic shortage of organ
donors.
This report addresses the consequences of that problem as reflected in the
changing trends in organ donation which have become evident in the five year
period between 1990 and 1994. Special attention is paid to the retrieval of
multiple organs from individual donors and the acceptance of organs from
donors who would have been previously considered as too old.
Waiting lists
The composition of the Eurotransplant waiting lists in 1990 and 1994 is set out
in table 1. The increasing disparity between the number of patients waiting for
a renal transplant and the number of renal transplantations performed is not
restricted to the Eurotransplant community [table 2], but is also observed
throughout Europe and in the United States.
An overview of the numbers of organ donations and transplantations in ET in
the same period is set out in table 3. Transplants of multiple organs from a
single donor to a single recipient are counted as one, irrespective of the
number of organs involved. Transplants of multiple organs from a single donor
to multiple recipients are counted as multiple transplants.
Table 1. Patients on the Eurotransplant waiting lists**
Organ 01-01-1990 31-12-1994
Kidney 10124 12849
Heart 402
Heart + Lung(s) 42
Lung(s) 46
Liver 220
Pancreas (+ kidney) 187
Totals 11021 14585
Difference between 1990 and 1994: 3564 = 32%
* Total non-renal organs
"Since 1991, Eastern Germany fully participates in Eurotransplant.
868
75
897* 243
33
216
1736*
1990*
1991
1992
1993
1994
10124
10463
11217
11956
12849
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Table 2. Kidney waiting list and transplantation in Eurotransplant
Year Size of Annual growth Transplants
waiting list waiting list (%)
3171
3 3395
7 3101
7 3293
7 2997
* Eastern Germany excluded
The substantial increase in the numbers of patients waiting for a transplant -
32% more in 1994 than in 1990 - did not result in a proportional increase in the
total number of transplantations, which rose by only 6% in the same period.
Almost 1800 of the patients on the waiting lists died in the period 1990 -1994.
The number of patients waiting more than 5 years for a renal transplant is
almost 10% of the total [2].
Non-renal donors and transplantations
The number of patients waiting for a non-renal organ increased from 897 in
1990 to 1736 in 1994, an almost two-fold increase [table 1]. In order to satisfy
the increasing demand for these organs, requests for multiple organ donations
were introduced into donor retrieval programs. The proportion of so-called
multi-organ donors (MOD) used in Eurotransplant in the study period in-
creased from 48% in 1990 to 64% in 1994 [table 3]. These values represent
a relative increase of 33% in 5 years. The numbers of non-renal transplanta-
tions (with the exception of heart transplantations), increased dramatically
during the study period. The number of transplantations per donor rose from
2.8 in 1990 to 3.1 in 1994, an increase of almost 13%.
Elderly donors
The acceptance of organs from elderly donors is clearly attributable to the
shortage of donor organs. In 1983, 10% of all kidney donors were aged
Table 3. Organ donation and transplantation in Eurotransplant between 1990 and 1994
(MOD =Multi Organ Donors: Transpl./Donors = Number of transplants from one donor)
Year
1990"
1991
1992
1993
1994
Donors
1615
1781
1622
1720
1544
%
MOD
48
54
57
61
64
Kidney
3171
3395
3101
3293
2997
Number of transplantations*
Heart
& Lung
682
806
753
773
696
Heart
19
24
32
28
43
Lung
50
71
109
119
138
Liver
576
715
765
878
892
Pan-
creas
72
74
67
100
95
Total
4570
5085
4827
5191
4861
Transpl./
Donors
2.8
2.9
3.0
3.0
3.1
a. each transplant operation is counted regardless the number of organs per transplant, except
for heart/lung transplants which are regarded as single transplants.
b. excluding former East Germany
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between 46 and 55 years, and only 2% were over 55. Gradually, donor
acceptance criteria changed and led to increased efforts and successes in the
retrieval of organs from donors previously considered too old.
In 1994, the retrieval rate in the two oldest donor groups was 23% [table 4].
Table 4. Proportion of elderly kidney donors in Eurotransplant
Year
1990
1991
1992
1993
1994
Number of
kidney transplantations
3171
3395
3101
3293
2997
46<55
N
694
758
696
740
698
DONOR AGES
%
22
22
22
22
23
>55
N
385
444
459
618
689
%
12
13
15
19
23
Causes of donor death
An overview of the causes of donor death in Eurotransplant in the 5-year study
period is presented in table 5. The most notable changes were in the number
of cerebral traumas, which decreased from 43% to 40%, and in the number of
cerebrovascular-accidents (CVA), which increased from 40% to 45%. In the
presence of the same number of organ donors, the former reflects consider-
able reduction in traffic accident fatalities, largely due to the use of seat belts
and helmets, while the latter is obviously related to the increased number of
elderly donors [table 6]. There were only slight changes in brain tumors,
suicide, and other.
Outcome of transplanted organs from elderly donors
The average age of 996 donors older than 55 years who provided kidneys to
Eurotransplant between 1990 and 1994 was 62 years. The survival rate of
primary renal allografts from donors older than 55 years was compared to that
of grafts from younger donors [table 7]. All cases of recipient death before graft
failure were excluded in order to avoid an unfair bias against elderly recipients.
The mean actuarial graft survival rate for transplants from donors aged 6-55
years was 89.7% (range 86-92%), and 85.2% (range 81 %-91 %) at three years
post-transplantation. The rates for grafts from donors in the youngest group
(0-5 years) were 78% at one year and 73% at three years, while those for grafts
Table 5. Causes of donor death in Eurotransplant 1990 to 1994
Cause of death 1990 1991 1992 1993 1994
Head injury
CVA*
Brain tumor
Suicide
All others
'cerebrovascular accident
43
40
3
4
10
41
42
3
5
9
40
43
3
4
10
39
45
2
4
10
40
45
2
4
9
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Table 6. Donor age and cause of death
Age (years) Head injury (%) CVA (%)
0 - 5
6 -10
11 -15
16-25
26-35
36-45
46-55
> 55
50
70
64
74
45
30
26
23
8
12
14
13
39
57
61
66
Table 7. Actuarial survival of primary renal allografts from donors in different age groups,
Eurotransplant 1990 to 1994
Donor age group
(years)
0
6
11
16
26
36
46
- 5
- 10
- 15
- 25
- 35
- 45
- 55
> 55
Case
190
220
249
1608
1291
1482
1584
996
1st year
% graft survival
3rd year
78
86
92
92
91
89
87
83
73
81
91
88
86
84
82
74
from donors in the oldest group (> 55 years) were 83% at one year and 74%
at three years post-transplantation (p<0.0001).
The survival rate of primary renal allografts from donors whose cause of death
was cerebral trauma differed significantly between younger (< 55 years) and
older (>55 years) donors: 86% and 79%, respectively, at three years post-
transplantation (p=0.03, [figure 1]). Graft survival rates of renal transplanta-
tions performed with organs from donors whose cause of death was CVA
were also analyzed according to donor ages. Grafts from younger donors
(< 55 years) did significantly better (p = 0.0001) than those from older donors
(> 55 years). The survival rates at three years were 85% and 72%, respectively
[figure 2].
Results with grafts from single and multiple organ donors
Multiple-organ donors (MODs) were mainly young, male donors who more
often died as a result of cerebral trauma than the single-organ (kidneys only)
donors (SODs). The MOD kidneys were transplanted into younger recipients
with lower pre-transplant panel reactive antibody levels and shorter cold
ischemia times, over a slightly less favorable DR mismatch gradient. These
grafts were more often preserved with the University of Wisconsin (UW)
solution than were SOD kidneys [2].
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An observational study was carried out by Smits et al on the results of 8746
MOD kidneys and 6610 SOD kidneys transplanted between 1988 and 1995 in
the Eurotransplant community [7]. Renal allograft survival was significantly
better for MOD kidneys (85%, 75%, and 58%) than for SOD kidneys (78%,
68%, and 46%); (p=0.0001). A multivariate analysis using Cox's proportional
hazards model was used to quantify the role of the two different procurement
policies, MOD and SOD, on renal allograft survival after adjusting for other
prognostic factors. Results showed that recipients of SOD kidneys had a
1.28 times higher risk of graft failure than recipients of MOD kidneys. The
superior graft survival of MOD kidneys could not be explained by the fact that
the MOD's were younger, male, and that UW was used as a preservation
solution.
Discussion
In most fields of human endeavor, excess demands for a product or service are
normally offset by increases in the production or availability of the service.
Unfortunately, that natural process does not function in clinical transplanta-
tion. Consequently, the increasing disparity between the number of patients
waiting for a transplant and the number of transplants performed is generating
a large amount of attention from governmental and public organizations.
Between 1990 and 1994, there was a 27% increase in the number of patients
waiting for a kidney transplant in Eurotransplant, while there was no increase
at all in the number of kidney transplantations performed. That disturbing trend
is evident not only in kidney but also in heart transplantation.
Renal transplantation continues to be the treatment of choice for patients with
end-stage renal failure. Consequently, it is not surprising that patients contin-
ue to be placed on waiting lists for such transplantations. However, the number
of organ donations still does not satisfy the requirements of those waiting lists,
which continue to grow. Attempts have been made to counter that trend via the
educational programs directed both at the general population and at the
specific medical communities. Transplant coordinators have been appointed
to expedite the numerous procedures involved in transplantation. There has
also been a number of different organs that may be retrieved from a single
donor as well as an increase in the acceptable age for organ donation.
The survival rate of kidneys transplanted from older donors - 83% at one
year - is lower than that from donors aged 6-55 years, which ranges from
86% to 92% at one year. The survival rate of the older grafts is 74% at three
years compared to 81-91 % for the younger grafts. Obviously, since transplan-
tation does not confer immortality on the graft, one should not be surprised by
the poorer performance of older grafts which may have a lower functional
reserve than younger grafts [3], Thus, one might consider introducing donor
age as a separate "match" criterion, especially for recipients over 55 years of
age.
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The significantly better results with MOD kidneys, which are not attributable to
the fact that MOD'S were younger, male, and that their grafts were preserved
with UW solution, may have been the result of the intensive surveillance that
potential MOD'S receive and the combined expertise of the multi-organ
explantation teams. Smits et al [4] have suggested that "every donor should
not only be considered as a potential multi-organ donor but, what is more
important, every organ should be treated as one".
The shortage of non-renal organs may be partly due to the fact that the routine
transplantation of these organs is relatively new and has not yet received the
same degree of public acceptability as renal transplantation. As such, the
number of patients awaiting such transplants may be expected to parallel the
increasing availability of those transplants. Indeed, the number of patients on
these waiting lists has almost doubled - from 897 in 1990 to 1736 in 1994 -
while the number of non-renal transplants only increased from 1399 to 1864
(33%). Once again, we are observing a serious disparity between the numbers
of waiting and transplanted patients.
Throughout Europe, many initiatives to increase organ donation rates, among
them transplant legislation, publicity campaigns, distribution of donor cards,
appointment of transplant coordinators and reimbursement of procurement
costs. Although all of these initiatives may help to increase organ donation,
none has been sufficient to make a significant impact on the supply of donor
organs [5],
In light of the continuing organ shortage, it is time to re-examine our strategies
to encourage organ donation. Two of the Eurotransplant member countries
with presumed consent legislation, Austria and Belgium, are demonstrating
that such a system is not only provides more donors, but also more organs per
donor [3]. Nevertheless, abandoning the system that most European countries
currently have, i.e. of voluntary, altruistic organ donation in favor of presumed
consent legislation is unlikely to be introduced. Poor results have been
achieved in France, whereas in some other countries, such as Spain, which
uses informed consent [6], better results have been achieved. Since 1990,
Spain has managed to dramatically increase the renal transplant rate - to 42
per million population in 1994-and to provide more donors per capita than any
other country. This has been achieved despite a continuing decrease in the
number of deaths from road traffic accidents, and has been attributed to the
coordination system and the support and training provided for transplant
coordinators [7].
Still, many potential donors are lost, because hospitals lack a clear process for
organ donation. Either potential donors are not detected or families are not
given the option of donation, or the manner in which the donation request is
made does not meet the family's emotional and informational needs. Despite
evidence of considerable public support for organ donation, many countries still
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report significant refusal rates. In 1994, data from United Kingdom Transplant
Support Service Authority (UKTSSA) and the Spanish Organizacibn Nacional
deTrasplantes(ONT) revealed national refusal rates of 26% and 24%, respec-
tively [7,8]. The Eurotransplant Foundation, concerned about the rise in organ
donation refusals, has taken the initiative of addressing this particular issue.
The European Donor Hospital Education Programme (EDHEP) was created in
1991 to meet the widely perceived need to help health professionals deal effec-
tively with bereaved relatives of potential organ donors. Its highly interactive
"skills awareness workshops" are moderated by qualified trainers who work to
sharpen the communication skills of medical professionals, heighten their sen-
sitivity to the needs of the bereaved relatives and teach them how to go about
requesting organ donation. The workshops provide participants with guidelines
for protocols for the care of the bereaved and for making requests for organ
donation. Since its inception, EDHEP has been translated into 17 languages
and is in use in over 30 countries [9] demonstrating the need for this kind of
professional training. Several countries are now beginning to incorporate ED-
HEP into their national medical and nursing training programs. A statistically
significant learning effect can be discerned in evaluations of the impact of ED-
HEP that are underway in the Netherlands and the United Kingdom. This ED-
HEP effect has also been shown in Israel and Japan. National Working Group
from all countries confirm that EDHEP adapts easily to all national, religious,
cultural, and educational needs. The program generates a more favorable atti-
tude to organ donation among critical care staff and teaches those involved how
to communicate more effectively and more confidently.
Recently, the Eurotransplant International Foundation (the Netherlands), ONT
(Spain), and the Partnership for Organ Donation (US) decided to integrate
their expertise into a program called "Donor Action", also designed to improve
the hospital donation process and to make sure that potential donors are
detected and families asked about donation in a sensitive and caring manner.
This program, combined with the training and support of the professionals
involved, is considered to be the most effective way to improve the donation
situation in individual hospitals. Research confirms that, with better practices,
hospitals can achieve a measurable increase in donation. Specific tools are
provided to ensure that all potential donors are identified early enough and
referred. Donor Action provides a comprehensive package of tools, resources,
guidelines, and training to help a hospital diagnose its own potential for
donation and improve its own organ donation procedures. The Donor Action
program materials are designed in a modular
- Donor detection - early identification of all patients who may be potential
donors.
- Donor referral - referral of all potential donors to transplant coordinators.
- Family care and communication - sensitive communication and support for
families of potential donors.
- Donor maintenance - optimal clinical management of potential donors.
- Organ retrieval - optimal retrieval protocols.
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It is hoped that this cooperative effort will have a beneficial effect on our efforts
to alleviate the organ shortage and help to provide treatment for patients with
end stage organ failure. .
Conclusion
The favorable graft survival results of MOD kidneys, which were significantly
better than those obtained with SOD kidneys, confirm their suitability for renal
transplantation.
The obtained results with grafts from donors older than 55 years were 5%
lower than those obtained from donors aged 6-55 years at one year and 8%
lower at three years. However, graft survival was much lower, and significantly
so, for organs from donors whose cause of death was CVA than it was for
organs from donors with cerebral trauma. Nevertheless, in view of the severity
of the organ donor shortage, we should continue to accept these organs for
transplantation.
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Introduction
Organs for transplantation are a scarce and precious resource. Although
organ donation rates have improved considerably in recent years, much more
needs to be done to reduce waiting lists and minimize loss of life. In this article
we present data gathered from a variety of sources relating to renal and
extrarenal transplantation for the period 1989-1996, and attempt to identify
trends in donation and transplantation rates. We also consider the possible
implications for future policy.
Methods
Countries where transplantation takes place were grouped into seven regions:
Western Europe, Eastern Europe, Latin America, the Middle East, Asia, North
America, and Australia, New Zealand, and South Africa as one region [table 1].
The number of renal and extrarenal (liver, heart, heart-lung, pancreas) trans-
plants were recorded according to donor type (cadaveric or living). Data were
compiled from both official sources, such as organ exchange organizations
(OEOs), and various scientific publications and internal reports from pharma-
ceutical companies [1-4]. Data from all sources were cross-checked against
one another.
Results
Donation
Published or well-corroborated estimates of numbers of organ donors for
every year in the period 1989-1996 were available only for North America and
Western Europe. The number of kidney donors available per annum increased
in both these regions in the period 1989-1996. In Western Europe, numbers
Table 1. Countries included in each of the seven regions studied
Region Countries included
Western Europe Austria, Belgium, Denmark, Eire, Finland, France. Germany, Greece, Italy,
Luxemburg, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland,
UK
Eastern Europe Byelorussia, Bulgaria, Croatia, Czech Republic, Estonia, Hungary, Latvia,
Lithuania, Poland, Romania. Russia, Slovakia, Slovenia, Ukraine
Latin America Argentina, Bolivia, Brazil, Chile, Columbia, Cuba, Dominican Republic, Ecua-
dor, Honduras, Mexico, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
Middle East Cyprus, Egypt, Israel, Iraq, Iran, Jordan, Kuwait, Lebanon, Libya, Oman,
Qatar, Saudi Arabia. Syria, Turkey, United Arab Emirates
Asia Bangladesh, Hong Kong, India, Indonesia, Japan, Malaysia, Pakistan, China,
Philippines, Singapore, South Korea, Taiwan, Thailand
North America USA, Canada
AusNZSA Australia, New Zealand, South Africa
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Number of renal donors
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•••Cadaveric donors - W. Europe A Cadaveric donors - N. America
*• Living donors - N. America a Living donors - W. Europe
Fig. 1. Number of donors used for renal transplantation in North America and Western Europe
between 1989 and 1996.
Living donors per million population
1989 1990 1991 1992 1993 1994 1995 1996
|-»North America * Western Europej
Fig. 2. A marked upward trend in the number of living donors was observed between 1989 and
1996 in North America. The number of living donors remained relatively stable during the same
period in Western Europe.
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rose from 5814 to 6740 [figure 1]. In North America the increase was more
substantial, with total kidney donors rising from 6057 to 8800. North America
used more living kidney donors than did Western Europe (3389 versus 943 in
1996) in spite of having a smaller total population (284.5 versus 378.4 million).
The number of living donors recruited in North America increased every year
in the period studied, while recruitment of living donors in Western Europe
changed little [figure 2].
There is evidence to suggest that the demographic profile of cadaveric donors
in these regions has changed. Eurotransplant Foundation records show that
the proportion of cadaveric donors aged over 55 years increased from 12% in
1990 to 21% in 1996 [5,6]. Over the same period, the proportion of donor
deaths due to head trauma (often caused by road traffic accidents) decreased
from 43% to 37%, and the proportion of donor deaths due to natural causes
increased from 48% to 58% [5,6]. Similar data were recorded in the USA by the
United Network for Organ Sharing (UNOS) [7].
Transplantation
The total number of transplants performed in Western Europe increased from
14,322 (1989) to 18,078 (1996). Most of this growth was in extrarenal
transplantation (4153 in 1989 to 6901 in 1996). The total number of renal
transplants changed little (from 10,169 in 1989to 11,177 in 1996). Inthe period
under review waiting lists for both renal and extrarenal transplants increased
faster than annual transplantation rates [figure 3].
1989 1990 1991 1992 1993 1994 1995 1996
=• Renal waiting list •*• Renal transplantations
•»Extrarenal transplantations^ Extrarenal waiting list
Fig. 3. Renal and extrarenal waiting lists and transplantations in Western Europe between 1989
and 1996.
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Fig. 4. Renal and extrarenal waiting lists and transplantations in North America between 1989 and
1996.
The number of transplants performed each year in North America increased -
from 14,677 (1989) to 21,613 (1996). As in Western Europe, extrarenal
transplants showed the greatest increase, from 4831 (91989) to 8712 (1996).
The total number of renal transplantations increased from 9846 (1989) to
12,901 (1996). Once again, the waiting lists for both extrarenal and renal
transplantation grew faster than the annual number of transplant operations
[figure 4].
Extrarenal transplants were relatively uncommon outside Western Europe
and North America, and accounted for just 10% of all transplants in Latin
America, 3% in Asia, 15% in the Middle East, 14% in Eastern Europe, and 18%
in Australia, New Zealand and South Africa. Renal transplantation predominat-
ed in these regions. The use of living kidney donors in these regions was
generally widespread [table 2].
More than half of all renal transplants in Latin America in 1995 were from living
donors. However, the long-term trend was an increase in cadaveric donation:
the proportion of kidney transplants from cadaveric donors was 29% in 1970-
88, 35% in 1989-92, and 51% in 1995. This change was driven by the small
number of countries that performed large numbers of transplants (Argentina,
Brazil, Chile, Cuba, and to a lesser extent, Mexico) and reflected changes in
government policy on transplantation, improvements in the structure of trans-
plant programs, and the introduction of new laws relating to donor consent [8].
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Table 2. Transplant activity (1995) in Latin America, Asia, the Middle East,
and Australia, New Zealand and South Africa (AusNZSA)
Latin
America
Asia Middle
East
Eastern
Europe
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Eastern Europe,
AusNZSA
Renal transplants
(living donor)
Renal transplants )
(cadaveric donor
Extrarenal
transplants
Tofa/
1985
1924
442
4357
10,000
700
281
70,96?
420
295
123
836
40
1610
260
7970
135
1005
244
7384
Living donation is very common in Asia and accounted for approximately nine
out of every ten kidneys transplanted. The majority of these procedures (an
estimated 6000 renal transplants in 1995) were carried out in India, a national
total exceeded only by the USA [9,10].
Most transplants performed in the Middle East were renal transplants. As in
Latin America and Asia, living donors are an important source of kidneys and
accounted for more than 50% of all transplant procedures. Many of these
activities are unregulated, although Iran is reported to have a legal system of
paid living donation [9].
Eastern Europe is unique in that virtually no renal transplants were carried out
using living donors. Renal transplantation programs in this region were
generally underdeveloped, but Hungary and the Czech Republic were notable
exceptions with cadaveric renal transplantation rates of 25.2 and 37.7 per
million population (PMP), respectively, in 1996. These figures compared well
with rates in the UK (26.2 PMP) and the USA (33.5 PMP).
Discussion
The number of renal and extrarenal transplants performed each year in
Western Europe and North America is increasing steadily. North America is
striking in its use of living donors, which is high compared with Western Europe
and is increasing every year. The reason for this may be partly economic, with
the health insurance system favoring transplantation over dialysis as a less
costly maintenance option for patients with end-stage renal failure. Ironically,
the relatively low rate of living donation in Eastern Europe may also have an
economic basis; under-investment prevents such procedures being per-
formed.
The supply of organs in all regions is failing to keep up with demand, and
waiting lists are continuing to grow year on year. Those patients lucky enough
to receive a transplant are increasingly likely to find themselves with an organ
from a so-called marginal donor - a donor aged over 55 years and possibly
who has suffered stroke. Recent data indicate that such organs may carry an
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increased risk of graft failure. The graft survival rate with kidneys from donors
older than 55 years is 5% lower than that with kidneys from younger donors at
one year and 9% lower at three years post-transplantation. Graft survival is
also significantly lower with organs from donors who die following cerebrovas-
cular accidents than it is with organs from donors whose death was due to
cerebral trauma [5].
There is a continuing, urgent need for 'good quality' organ donors. The
discovery that graft survival rates using kidneys from living donors are
superior to those obtained with cadaveric donors led to the suggestion
that increased use of living donors, as seen in North America, could help
to reduce waiting lists [11]. However, it is unlikely that more than 35% of
renal recipients will find a suitable match with a living donor, leaving a gap
that must be filled by cadaveric donation. In addition, increases in living
donations will have little impact on extrarenal transplants, which almost
invariably require cadaveric donors. The relatively small numbers of
living donors currently used, together with the legal and ethical restrictions
already in place in North America and Western Europe, mean that living
donations alone are unlikely to resolve the organ shortage. Even regions with
historically high levels of living donation, such as India and parts of Latin
America, have enacted, or are in the process of enacting, legislation designed
to limit the use of living unrelated donors and stimulate the search for
cadaveric donors.
Transplant legislation is important because it provides a framework within
which cadaveric organ donation can take place. In practice, this means the
adoption of one of two basic forms of consent law: 'presumed consent' or
'informed consent'. Presumed consent allows individuals to record their
objection to organ donation. If no objection is registered - mostly on a central
computerized database - then the organs may be procured. It is not usually
legally necessary to inform relatives of the intention to remove organs, and
rates of objection using this system appear to be low (0.5-24%) [12]. With
informed consent, if an individual has not recorded his or her wish to be an
organ donor, consent must be obtained from the next of kin. This is always a
difficult interview for both the doctor and the recently bereaved relatives, and
refusal rates in these situations remain understandably high [13]. As might be
predicted, when ranked by cadaveric donation rate, four of the top six
countries in Western Europe and North America practice presumed consent
legislation [table 3].
These data should be treated with caution as the relationship between
procurement legislation and the practice of organ procurement is not straight-
forward. Interpretation of the law varies between nations, hospitals, and even
doctors. These variations can be so great as to effectively over-rule the
legislation. Thus Spain, the country with the highest procurement rate, has
chosen not to practice its presumed consent legislation and, instead, operates
a de facro informed consent system, and France and Greece, which also have
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Table 3. The number of cadaveric donors in Western Europe and North America in 1996 and
the prevailing donor legislation
Spain
Austria
USA
Belgium
Portugal
Finland
Ireland
The Netherlands
Norway
France
Canada
Denmark
UK
Germany
Switzerland
Sweden
Italy
Greece
Cadaveric ^/dney
donors per m/7//on
popu/at/on
26.8
24.7
21.2
21.2
21.2
19.5
17.7
15.1
15.1
15.1
15.0
15.0
14.2
12.7
12.6
11.9
11.0
6.5
Donor's /ega/
s/fuaf/on
presumed consent
presumed consent
required request
presumed consent
presumed consent
presumed consent
informed consent
informed consent
presumed consent
presumed consent
informed consent
informed consent
informed consent
informed consent
presumed consent,
informed consent,
or no law
presumed consent
presumed consent
presumed consent
Donor's s/fuaf/on
/n pracf/ce
informed consent
presumed consent
informed consent
presumed consent
presumed consent
presumed consent
informed consent
informed consent
informed consent
informed consent
informed consent
informed consent
informed consent
informed consent
practice varies
per canton
practice varies
informed consent
informed consent
presumed consent laws, procure relatively few organs [2].
It is evidently important both for individuals to become organ donors and for
consent, once asserted, not to lapse. If relatives are to be consulted following
an individual's death, they should beawareof, and sympathetic to, the benefits
that organ transplantation can bring to the recipient. The attitudes of potential
donors and their relatives to transplantation medicine and ethics may have a
crucial bearing on their decision to give consent for donation. There is some
evidence to suggest that these attitudes may be influenced by transplantation-
related stories in the media. These stories include the alleged theft and murder
of babies in Latin America so that their organs can be used for transplantation
in North America and Europe, rumors of international organ trafficking,
allegations that organs of executed prisoners are used for transplantation in
the People's Republic of China [14]. Most of these stories remain entirely
unproven [15], while others may be relatively well verified but have no bearing
on transplantation as it is practiced in Western Europe and North America.
However, the consequences of such stories may be far-reaching; for example,
the transmission of the 1993 TV documentary Vo/eursD'Organes that purport-
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ed to show evidence of child organ trafficking coincided with a significant
reduction in levels of organ donation in France later that year [2].
Such stories are often linked to important ethical questions which must of
course be openly debated. However, if the issues are not clearly defined and
misinformation quickly denounced, public misunderstanding about organ
transplantation will be encouraged and cadaveric donations may plateau or
even decrease. We propose that the question of information management be
addressed directly by a permanent international human donor surveillance
committee comprising transplantation physicians and by OEOs. Using in-
ternational human rights monitoring organizations as a model, the committee
would have the following core activities:
To serve as a clearing house for information on organ donation activities.
To this end, the committee would publish an annual survey of organ donation
practices, containing basic information on demographics, donation rates, and
legal issues. A separate report would focus on more problematic areas, such
as the sale of organs, the use of organs from executed prisoners, allegations
of organ theft and so on.
To review the positions of international organizations, and to discuss
current ethical issues surrounding transplantation.
The key purpose of this review would be to highlight relevant ethical issues,
and to act as a forum for subsequent debate.
To make recommendations to medical and human rights groups regard-
ing appropriate strategies for enforcing international standards.
As a non-affiliated body, the committee would be well placed to offer advice to
both national and international organizations.
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Introduction
Organ donation is a unique process that can take place only with the co-
operation of the many parties involved, such as donors, families, and medical
staff, as well as government and society as a whole. Even with such co-
operation, the steady progress made in the last 10 years in the field of organ
transplantation has been seriously hampered by one persistent problem: a
worldwide shortage of donor organs. As the number of patients on transplant
waiting lists continues to rise, the number of transplants performed in the US
and most of Europe in recent years has levelled off [figure 1]. It is now
imperative to organize the procurement of organs so that waste is minimized
and the supply of organs is increased.
Many countries have developed national systems for organ procurement and
allocation that comprise various combinations of legislation, organ exchange
organizations (OEOs), the appointment of transplant coordinators, publicity
campaigns, donor cards, and training programs. Although these measures
have minimized organ waste, none has so far proved sufficient to solve the
problem of donor organ shortage. OEOs play an important role in initiating
donation programs and, we describe their role in the organ procurement
process that precedes allocation and transplants and some of the methods
used to increase organ supply.
Development of OEOs
The efficient use of donated organs depends on the pool of patients awaiting
transplants; the larger and more diverse the waiting list, the higher the chance
of using the available organs. However, most early transplant programs
operated locally and maintained only short waiting lists, which often meant that
suitable recipients could not be found for the available organs. As the number
and type of transplant procedures increased, the problem grew, and the need
for a centralized organization to coordinate organ procurement and allocation
became evident. The OEOs were created in response to this need and now
ensure that as many available organs as possible are transplanted. In
addition, OEOs also oversee fair, transparent, and objective organ allocation
policies that ensure the best possible match between donor and recipient and
that patients in the most urgent need are given priority.
Initially, most OEOs were private initiatives based on the recognition of the
special benefits widespread professional collaboration could achieve in trans-
plantation. OEOs were voluntary associations between co-operating trans-
plant programs. Each transplant program is comparable to a member of a club
who agrees to abide by the club's rules, and the OEO, as the club secretary,
is the custodian and implementor of the rules. As such, the OEO must strike
a delicate balance between satisfying the demands of the individual transplant
programs and maintaining the integrity of an organization that represents all
its members [1].
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The Widening Gap 1993-1998
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Figure 1. Difference between organ supply and demand in the USA and Eurotransplant (Austria,
Belgium, Luxemburg, Germany, the Netherlands) 1993 - 1998.
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Most OEOs operate on a national basis. In some countries, such as the US, the
national organization is the result of an alliance between regional agencies. In
Europe, for some organizations, cooperation has always been international,
thus the Eurotransplant Foundation serves Austria, Belgium, Germany, Lux-
emburg, Slovenia (since January 1, 2000) and the Netherlands; United King-
dom Transplant serves the UK and Eire; and Skandiatransplant serves Den-
mark, Finland, Iceland, Norway, and Sweden. In contrast, in Italy several
regional organizations continue to operate independently [table 1].
There is wide variation in the areas and populations covered by each of
the European OEOs. For example, in Spain the OEO covers an area of
0.5 million km^and a population of 40 million people, but in Scandinavia the
Table 1. European Organ Exchange Organizations*
Name
Eurotransplant
Etablissement Francais des Greffes
United Kingdom Transplant
Scandiatransplant
Swisstransplant
Organizaciön Nacional de Trasplantes
Organizacao Portuguesa de
Transplantacao
Poltransplant
No national, but three regional
organizations (NITp, AIRT, Centro-Sud)
Hungarotransplant
Czechtransplant
Hellastransplant
Total population
Countries
Austria
Belgium
Luxemburg
Germany
The Netherlands
Slovenia (since January 1
2000)
France
UK + Ireland
Denmark
Finland
Iceland
Norway
Sweden
Switzerland
Spain
Portugal
Poland
Italy
Hungary
Czech Republic
Greece
Total population x10*
118
60
62
24
7
40
10
39
58
10
10
10
448
*No data available from the Republics that formed the former Yugoslavian Federation
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OEO is responsible for an area of 1.1 million km^anda population of 24 million
people. Eurotransplant is the largest OEO in Europe and serves an area of 0.5
million krri2 and a population of 116 million people. This includes 64 renal
transplant centers, 44 heart transplant centers, 15 lung transplant centers, 36
liver transplant centers, and 21 pancreas transplant centers.
In the last decade, donation systems, transplant programs, and OEOs have
received increasing attention from government and, in some countries, such as
Spain and France, the organizations are now formal, governmental organiza-
tions. In others, such as the UK, the OEO is a non-governmental body attached
to the Department of Health. Although governments are not closely involved
with the OEOs of other countries, such as Austria, Belgium, Denmark, Sweden,
Germany, and the Netherlands, legislation has been introduced in these coun-
tries to regulate the diagnosis of brain death, the consent process, organ pro-
curement, transplants, and the licensing of centers to perform transplants.
Function and infrastructure of the European OEOs
European OEOs have developed into an alliance between donor hospitals
(input), transplant programs (output), and tissue-typing laboratories. They are
non-profit bodies that act as service agencies to both donating hospitals and
transplant units, and they all follow the same set of general policies, operating
procedures, and organ allocation rules.
The main functions of the OEOs are diverse and vary from country to country.
They include the following:
- Maintenance of patient waiting lists for all varieties of organ and tissue
transplants
- Allocation of available organs and tissues to appropriate patients, accord-
ing to agreed on medical criteria that include clinical urgency and waiting
time
- Maintenance of records on the source and destination of all organs and
tissues
- Collection of data on the postoperative transplant course and acting as a
data reference center through continuous analysis of the database
- Research and quality control
- Reimbursement of costs to donating hospitals and procurement teams
- Support and promotion of initiatives to increase organ donation
- Co-operation with other OEOs in the event of a clinical emergency or if no
suitable recipient can be found in the country of donation
- Participation in tissue banking and inclusion on bone-marrow donor regis-
tries
In general, OEOs have developed a hierarchical decision-making process that
guarantees equal representation of all the geographical regions and trans-
plant programs covered by the organization. Policy is overseen by medical
advisory committees specializing in each type of organ or tissue transplant,
tissue-typing, organ procurement, and ethics. Changes in policy initiated by
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the committees must be approved by the board of the OEO and government,
if involved.
Transplant coordinators
An acknowledgment of the need for local as well as national and international
organization of organ transplants led to the introduction of transplant co
ordinators (TCs). Transplant coordinators first appeared in the US in the 1970s
and were typically renal technicians and nurses who were already working in
transplant units. As the demand for transplants grew, the responsibilities of
TCs expanded and they were appointed in a full-time capacity to concentrate
on the elaborate donation and procurement process, as well as community
and professional education [2]. This initiative was quickly adopted in Europe,
where the first TCs were appointed in the late 1970s. All European countries
with transplant programs now employ TCs, and they have become the linchpin
between transplant centers and intensive care units (ICUs).
The role of the TC involves the following:
- Developing professional links between transplant units and nearby ICUs
- Establishing hospital protocols and procedures for organ donation
- Helping hospital staff with the tasks involved in the process of organ
donation, including approaching bereaved relatives to ask for permission
to remove organs for transplants
- Providing professional and, to a lesser extent, public information on organ
donation and transplants.
In most European countries, TCs are based in transplant units. In contrast, in
the US, many procurement coordinators have removed themselves altogether
from transplant centers and provide a service to donating hospitals and
transplant units through independent organ procurement organizations [3].
The organ procurement process
Most countries recognize brain death, and it is usually defined as the total and
irreversible loss of brain function. If organ donation is a possibility, brain death
must be established by physicians not involved with the organ procurement
team. Once the diagnosis of brain death is confirmed and consent to remove
the organs and/or tissues has been obtained, the TC arranges a suitable time
for this to occur. At this point 'patient care' becomes 'donor maintenance', and
the aim is to maintain optimal organ function for the benefit of recipient
patients. Donor management can be difficult, costly, and time-consuming, and
organs may be 'lost' at this stage. A high standard of medical and nursing care,
is therefore, essential. It is important to remember that this change in empha-
sis may be distressing for the ICU staff, and, as a result, the responsibility for
donor management is frequently undertaken by procurement TCs.
TCs are responsible for the local organization of organ donation and commu-
nicate closely with the OEO throughout the process. When a potential donor
becomes available, the TC, who may travel to the donating hospital, must
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determine whether the organ(s) and/or tissues are suitable for transplant. The
donor's medical history is carefully examined and his or her current medical
status is evaluated. This process frequently necessitates further investiga-
tions. Once collected, all relevant information is relayed to the OEO that will
eventually allocate the available organs.
Ethical and legal issues
The ethical issues surrounding transplantation have come under close scru-
tiny in most countries, and legislation has gradually been introduced to
regulate the transplant process and to protect donors. However, few countries
have introduced legislation that comprehensively deals with organ or tissue
donation by living or deceased donors. Most countries have introduced
legislation to clarify the diagnosis of brain death and to control the consent
process and the methods used to monitor the source and destination of donor
organs and tissues [4]. In general, legislation also aims to ensure that living
donors are not coerced to donate, especially if they are minors or if they are
mentally ill, and that neither donors nor physicians gain financially from
donation. In addition, measures to prevent 'transplant tourism' - the move-
ment of prospective donors and recipients to other countries - are gradually
being instituted.
Improvements in legislation on driving and health and safety at work has led
to a reduction in accidental deaths [5]. This welcome change coupled with the
steadily increasing number of patients requiring transplants has contributed to
the worldwide shortage of donor organs that now exists. Furthermore, despite
strong public support for organ donation, rates of refusal to donate remain
relatively high. For example, in 1994, data from UK and Spain revealed
national refusal rates of 26% and 24%, respectively [6,7].
A recent study in the Netherlands revealed refusal rates as high as even 73%
[8]!
Families give many reasons for refusing organ donation, such as worries
about the meaning of brain death and the integrity of the corpse, and religious
and social objections. Differences need to be taken into account. In addition,
wide differences in refusal rates between countries suggest that the method
and timing of the request for donation probably also influences the outcome.
Efforts to reduce the barriers to organ donation include schemes in which
individuals may register their objections to organ donation ('opt-out' or 'pre-
sumed consent' schemes) or schemes that require potential donors to carry
donor cards indicating their wish to be an organ donor or register with a central
computerized system ('opt-in' schemes). In general, despite such schemes,
the families of potential donors who carry donor cards or have registered their
desire to be an organ donor are still consulted before organs or tissues are
removed. The system, therefore, relies heavily on good communication within
families. In countries that operate opt-in schemes, the families of potential
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donors who do not carry donor cards are also approached and given the
opportunity to donate.
Opt-out or presumed consent schemes enable either verbal or computer
registration of an individual's objection to organ donation and, in some
countries, the register is available to transplant units. Opt-out schemes do not
usually require the relatives of the donor to be informed before the organs or
tissues are removed from the body. Although opt-out schemes do seem to
provide impressive donation rates in most, but not all, countries, it is difficult
to compare donation rates between countries because individual hospitals
and doctors often interpret the prevailing regulations differently [table 2] [9].
For example, Belgium operates a 'presumed consent' legislation and it
consistently has one of the highest numbers of donated organs per million of
the population [10]. Other countries, such as France, that have similar
legislation have not achieved comparable donation rates [11].
In the US, refusal rates are reported as high as 38%. Consent rates went up
to 74% when the following three elements were present in the donation
Table 2. The number of cadaveric donors in
donor legislation
Spain
Czech Republic
Belgium
USA
Portugal
Austria
Finland
Hungary
Norway
France
UK + Ireland
The Netherlands
Switzerland
Germany
Sweden
Italy
Denmark
Poland
Greece
Cacraver/c l(/cfney
donors per mi///on
popu/af/on
29.0
23.2
22.5
21.3
20.5
19.5
16.3
15.4
15.1
15.0
14.5
14.4
14.3
13.2
12.6
11.6
11.4
6.9
3.7
Europe and the USA in
Donor's /ega/
s/fuaf/on
presumed consent
presumed consent
presumed consent
required request
presumed consent
presumed consent
presumed consent
presumed consent
presumed consent
presumed consent
informed consent
informed consent
presumed consent,
informed consent, or
no law
informed consent
presumed consent
presumed consent
informed consent
presumed consent
presumed consent
1997 and the prevailing
Donor's s/fuaf/on
in pracf/ce
informed consent
presumed consent
presumed consent
informed consent
presumed consent
presumed consent
presumed consent
presumed consent
informed consent
informed consent
informed consent
informed consent
practice varies per
canton
informed consent
practice varies
informed consent
informed consent
informed consent
informed consent
A European perspective on organ procurement - breaking down the barriers to organ donation 65
process: the family understood the concept of brain death before the request
for organ donation was made, the request took place in a quiet place, and the
TC participated in the request for donation [12].
In addition, in the US, in case of brain death in which the patient may be a
potential donor, physicians are required to ensure that families are ap-
proached and given the opportunity to consider organ donation, a process
known as 'required consent'. However, even in the presence of this mandatory
process, not all families are approached and a high proportion of potential
donors are missed.
Whichever system is used to increase organ availability, all relatives of donors
must be reassured of the effectiveness and usefulness of organ donation. A
special understanding of the religious and social beliefs of ethnic minorities is
also needed to optimize donation rates among all people within a country. In
addition, donation rates might increase if organ donation was focused on the
ICU and regarded as a specialty in its own right. As such, it would attract
increased funding for improved training and research.
Improved training
Training seems to play an important role in achieving high donation rates. With
a renal transplant rate of 46.9 per million of the population (live and cadaveric),
Spain had the highest rate in 1997. This was achieved despite a continuing fall
in deaths from road traffic accidents and was attributed to a combination of an
effective procurement and allocation system and well-trained and supported
TCs [7,11]. In contrast, lack of training in the US often leads to requests for
donation not being made and high refusal rates because of poor support for
donors' families [13].
To improve training and, therefore, reduce refusal rates, Eurotransplant
created the European Donor Hospital Education Programme (EDHEP) in
1991. The aim of EDHEP is to help health professionals be more effective
when dealing with bereaved relatives. Interactive workshops, moderated by
qualified trainers, are available to all critical-care staff who wish to sharpen
their communication skills, heighten their sensitivity to the needs of the
bereaved, and learn ways of requesting consent for organ donation.
Since its inception EDHEP has been translated into 17 languages and is in use
in over 30 countries and several countries have incorporated the program into
national physician and nurse training. When questioned about the usefulness
of EDHEP, both doctors and nurses who took part reported that they felt more
confident in dealing with donors' families, were more willing to request
donation, and were better informed about brain-death criteria and the legal
and religious objections to organ donation in their countries [14]. When
participants' knowledge was tested before and two weeks and 6 months after
taking part in EDHEP, they showed improved knowledge, improved confi-
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dence in dealing with the bereaved and, most important, were more likely to
make donation requests than professionals who had not taken part in the
program. In addition, the program has also been shown to increase donor
referral through increased national and international collaboration between
professionals [14].
The Donor Action Programme
An example of effective international co-operation is the Donor Action Pro-
gramme - a collaboration between the Eurotransplant Foundation (the Neth-
erlands), Organizaciön Nacional de Trasplantes (Spain), and The Partnership
for Organ Donation (US). In 1993, these organizations agreed to pool their
different areas of expertise in donation to alleviate the worldwide shortage of
donor organs.
The Donor Action Programme provides tools, resources, and guidelines for
hospitals to define their potential for donation and to develop an effective
protocol to improve their donation practices. In the first phase, a hospital-
based committee performs a diagnostic review to collect information on its
current donation situation. Diagnostic tools are a retrospective medical
records review (MRR), a hospital attitude survey (HAS) of critical care staff,
and a software package to analyze the data. In the second phase, the
committee uses the database analysis to identify specific areas for improve-
ment and education for key staff in the donation process. In the third phase,
the Donor Action Programme modules are used to effect changes in one
or more of the following specific stages in the donation process: donor
detection, donor referral, family care and communication, donor maintenance,
and organ retrieval. Data are then collected on an on-going basis to monitor
progress.
Between 1994 and 1996, the Donor Action Programme pilot evaluations were
undertaken in 11 hospitals in the Netherlands, Spain, the UK, and Canada.
Data from the pilot diagnostic reviews showed significant potential for im-
provement in donation rates. Aggregated MRR results on the basis of 579
medical records of patients who died in ICUs showed no obvious contraindi-
cation to donation in 398 (68%) patients. However, only 124 (31%) of these
individuals became donors. In all pilots, most problems occurred in donor
identification and/or management (166 cases: 42%) and family or coroner
refusals (104 cases: 26%) [15].
Aggregated HAS data from 2129 critical-care medical and nursing staff reveal
consistently strong support for organ donation. However, the surveys also
reveal that many staff do not feel comfortable performing key tasks close to
donation. Belief that organ donation saves lives (97%), support for donation
(94%), and willingness to donate organs (79%) were high in all country
samples. However, significant differences exist between countries, hospitals,
and individual ICUs in self-reported skills in donation-related tasks. For
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example, 77% of UK respondents reported themselves skilled or comfortable
explaining brain death, compared with only 57% of Dutch respondents, 50%
of Canadian respondents, and 12% of Spanish respondents. Similar varia-
tions were seen when staff were asked how they felt about requesting organ
donation: in the UK 52% of staff felt comfortable requesting donation com-
pared with 40% of Dutch respondents, 33% of Canadian respondents, and
13% of Spanish respondents [15]. It is interesting that fewer staff in Spain feel
prepared to request donation than in the other countries, yet Spain has the
highest donation rates. This may reflect the degree to which staff with a
specialized role in donation have been successfully integrated into hospital
practice.
Data from the Donor Action Programme pilot hospitals have identified a
significant number of unused donors and also suggest that there may be
important differences in attitudes and perceived skills and comfort between
countries. The diagnostic review has proved useful in identifying problem
areas in the hospital donation process and providing a baseline against which
to monitor progress. In addition, the MRR can effectively identify untapped
donation potential and, when matched with the HAS, can be used to customize
the Donor Action Programme to individual hospital requirements. To date,
there has been a lack of information on the attitudes of hospital staff to organ
donation to enable comparisons between countries to be made and to support
targeting of strategies to the specific needs of different countries. The Donor
Action Programme pilot results demonstrate the feasibility of collecting and
comparing data across national systems. The pilot data and medium-term
results from Spain and the UK also suggest that the program will offer long-
term benefits.
Other factors
Other factors that influence organ availability include media reports and costs.
The media play an important role in influencing attitudes towards organ
donation, in both negative and positive ways and may also influence legisla-
tion. Dramatic newspaper stories revealing, for example, the sale of organs or
the removal of organs without permission, inevitably adversely affect donation
rates. However, stories on, for example, the plight of children requiring liver
transplants boost transplant programs and donation rates and the need to co-
operate with the media is now well understood.
A greater awareness among physicians of the costs and quality of life benefits
of transplants may help improve the likelihood of families being offered the
opportunity to donate after the death of a relative and increase donor organ
availability. Transplants are costly procedures, but increasingly, they compare
favorably with the cost of other forms of treatment, such as dialysis, nursing
seriously ill patients, and patients not being able to work. One study in the US
found that a 20-year savings of $11,000 per patient could result from renal
transplants [16].
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Conclusion
Transplants are now an accepted form of medical treatment and, since the first
transplants were performed, many thousands of lives have been saved or
improved. However, the process leading from donation to transplant is com-
plex and influenced by many factors, such as legislation, training, public
attitudes, and costs. Such factors also influence organ donation, and the
worldwide shortage of donated organs is the major challenge currently facing
transplant programs around the world.
Several attempts have been made to improve donation rates, such as pre-
sumed consent legislation and more effective training programs to improve the
way bereaved families are approached and, therefore, increase the likelihood
of obtaining permission to remove organs or tissues from the deceased
relative. In addition, the transplant community itself has taken steps to ensure
that procurement and allocation criteria are efficient, fair, objective, and
transparent. However, organ donation rates remain too low, and difficult
questions such as the following need to be answered if the supply and demand
for transplantable organs are to be better matched:
- Should transplants be limited by age or disease?
- Should re-transplantation be an option for patients whose first graft fails?
- Should the lives of living donors be endangered in the quest for organs?
- Should we encourage donation from living relatives and friends of the
potential recipient?
- Should organ donation be rewarded in some way?
- Should organs or tissues from other species be transplanted into patients?
The problems associated with transplants are international and, until alterna-
tive forms of treatment become available, the aim of health professionals must
be to join forces in an international effort to share initiatives aimed at
optimizing the donation process. An example of effective international co-
operation is the Donor Action Programme. The program provides an opportu-
nity to change donation practices and create appropriate education strategies
in hospitals. Such a co-operative effort will help alleviate the organ shortage
and help provide the best possible chance of treatment for patients requiring
transplants.
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The origins of EDHEP
The Eurotransplant Foundation (ET) is an Organ Exchange Organization
(OEO) based in Leiden, the Netherlands. ET provides a service for the
Netherlands, Germany, Austria, Belgium and Luxemburg, which covers a
population of over 116 million people. In 1990, the ET region experienced a fall
in organ donation that resulted in a further increase in the gap between the
supply and demand for donor organs.
Seeking a reason for these trends, researchers in ET discovered that many
medical professionals within the five countries were still unaware of the needs
of transplantation and in many hospitals protocols and procedures for organ
donation were not available. Additional data show that as many as 30% of
potential donors were lost because of a refusal by the family [1 ]. This was often
the result of difficulties in understanding the concept of brain death and
misconceptions about the procedures of organ donation. The researchers felt
that part of these misconceptions may have been the result of inadequate
communication between the doctor and nurse and the relatives.
Following this train of thought a literature search was undertaken on the
attitudes of doctors and nurses towards this subject. This review revealed that
the difficulties staff say they have can be grouped under three headings:
1. The important role that the professional's own feelings towards death and
organ donation can have in inhibiting the donation request.
2. Worries about intruding on a family's grief.
3. Lack of experience and training in approaching bereaved relatives.
These findings are supported by research from the United States [2].
The development of EDHEP
Eurotransplant wanted to tackle the problem of the growing donor shortage
and is the driving force behind the development of EDHEP. In 1991, with the
generous support of the Dutch Kidney and Heart Foundations, ET developed
a professional education program for the Netherlands. Later, appreciating the
value of a prototype that could eventually be adapted for use throughout
Europe, Sandoz Pharma in Basel, Switzerland also agreed to support the
development of what became EDHEP. The program is part of a multifaceted
process aimed at closing the gap between the supply and demand for organs
and tissue for transplantation. It was created to meet the widely perceived
need to help doctors and nurses feel effective in dealing with the bereaved and
in requesting organ donation. EDHEP was produced by professionals from
different specialties including medical doctors and clinical psychologists from
the University of Maastricht, transplant coordinators (TCs) and communica-
tions specialists in close collaboration with The Rowland Company [figure 1].
The prototype was designed to be easily translated into different languages,
adjusted to meet national circumstances and cultures and to complement
other existing educational programs. With the help of the regional TCs a Dutch
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Eurotransplant Sandoz Pharma
Dutch Kidney & Heart Foundations
European Advisory Committee
T
TASK FORCE
Eurotransplant Maastricht University
Rowland Company/Sandoz
t
Create Adaptable Prototype Dutch Pilots
Figure 1 EDHEP-development
version of the program was piloted in three regions in the Netherlands in 1991.
The participants were relatively experienced doctors and nurses, although
some had never been involved in requesting organ donation. Following minor
adjustments EDHEP was introduced as a professional educational tool in the
Netherlands and in 1992 was made available to other interested countries
[figure 2].
Program objectives and content
The objectives of EDHEP are to:
Eurotransplant Foundation + EDHEP Coordinator
Establish National Working Group
Participate in Train The Trainers Courses
Develop National Programs
Figure 2 EDHEP-national implementation
1. Raise professional awareness of the problem of the donor shortage and to
provide some possible solutions.
2. Develop an awareness of the needs of the bereaved between medical
professionals and the needs of the professional in dealing with the be-
reaved.
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3. Provide "hands-on" communication skills training in dealing with grief
reactions and requesting organ donation.
4. Provide guidance on setting up hospital protocols for dealing with bereaved
relatives.
EDHEP is produced in two parts. EDHEP Part 1 is called "Meeting the Donor
Shortage". The aim of Part 1 is to raise the awareness and understanding of
organ and tissue donation and transplantation among all levels of medical,
nursing and paramedical staff in all hospital departments. "Meeting the Donor
Shortage" is an informative slide presentation that covers the history and
current state of the art in organ and tissue transplantation. It also outlines
some reasons behind the growing donor shortage and puts forward some
possible solutions to the many problems that surround this area of medicine.
Many countries already have TCs who regularly provide this type of informa-
tion to hospital staff. The material is available both to those countries who wish
to supplement their existing educational programs and countries who are not
yet providing this type of educational service. Slides and suggestions for
overhead transparencies, which can also include statistics and information of
local interest, are provided. The presentation takes about one hour and is
intended to be given in hospitals, at an appropriate time, by TCs or other
transplant personnel.
EDHEP Part 2, is named "The Grief Response and Donation Request". Part 2
takes the form of a highly interactive one-day skills awareness workshop,
conducted outside the hospital setting, well away from bleeps and telephones.
"The Grief Response and Donation Request" workshop is organized and
introduced by the local TCs but is moderated by communications skills
experts. The workshop is targeted at professional staff working in any area of
medicine that brings them in contact with bereaved relatives. It aims to help
participants improve their communication skills and heighten their sensitivity
to the needs of the bereaved. In addition, participants learn ways to break bad
news and discuss organ donation with the bereaved. With the help of exercis-
es and teaching video tapes the EDHEP workshop encourages participants to:
1. Examine their own feelings aroused by loss and separation.
2. React to different grief reactions with an appropriate professional re-
sponse.
3. Listen to bereaved relatives describe their feelings of loss and donation.
4. Analyze problems of miscommunication.
5. Participate in skills training with simulated bereaved relatives.
6. Discuss ways of establishing hospital protocols for dealing with the be-
reaved.
Adaptation and implementation of EDHEP
To ease the national adaptation and implementation of EDHEP a coordinator
was appointed in 1992, based at ET. The role of the coordinator is to identify
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countries with an interest in adopting EDHEP and to provide advice and
assistance in five areas:
1. The formation and composition of national working groups. The national
working groups [table 1] are responsible for adapting the EDHEP educa-
tional material to their own language and needs. The group is also
responsible for the national setting up and evaluation of the program.
2. The acquisition of workshop moderators and simulated bereaved relatives.
It is not necessary initially that the moderators are familiar with donation
procedures, the ideal moderator being described in table 2. However, this
knowledge is important when running the EDHEP Part 2 workshops and
can be provided under the supervision of the national working group.
Simulated bereaved relatives are used to enhance the authenticity of the
separate role play exercises when participants are asked to break bad
news and request organ donation.
3. Organize "Train The Trainers" (TTT) courses. The TTT courses are interna-
tional training courses for national working group members and potential
EDHEP workshop moderators. The courses are run, in English, by the
EDHEP international coordinator and clinical psychologists from the Uni-
versity of Maastricht, the Netherlands. The main purpose of these courses
is for participants to gain familiarity with the content and format of the
program. Training in moderating the different modules is provided for
potential EDHEP Workshop moderators. National working group members
are made aware of the variety of activities needed to adapt and set up the
program in their national environment. Finally, the TTT course aims to
establish a close dialogue between EDHEP national working groups and
the EDHEP international working group.
4. Guidance and assistance with the national adaptation of the EDHEP
educational material.
5. Ensure a degree of program quality assurance. Countries are asked to sign
a contract with ET. The purpose of the contract is to preserve the spirit and
quality of EDHEP during its adaptation and implementation and to ensure
that adequate training, help and guidance is provided by the international
EDHEP coordinator.
The costs involved in the translation, adaptation and application of EDHEP
have, for the main part, been borne by the national Sandoz affiliates. Additio-
Table 1. Composition of National EDHEP Working Groups
The ideal working group could comprise members of the following organizations:
National Transplant Societies
Intensive care/neurosurgical societies
National medical/nursing associations
Transplant coordinators' organizations
Communications skills trainers
Public Relations specialists
Religious advisors/community leaders
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Table 2. Workshop moderators and simulated bereaved relations
The ideal EDHEP Workshop Moderator should have the following background experience:
Knowledge of behavioral skills
Experience in communication skills training
Familiarity with the psychological aspects of bereavement
Familiarity with the nature of the medical professional's work in a hospital environment
Familiarity with donor procedures
Experience with using a variety of educational material
Suitable EDHEP Moderators can be found among:
Bereavement counselors
Clinical psychologists
Crisis Care counselors
Educational psychologists
Communication skills training experts
Simulated Bereaved Relatives:
The University of Maastricht has a tradition of using local volunteers as simulated patients
during the training of medical students. A simulated bereaved relative is a non-professional
actor, trained in playing a prescribed role and giving feedback. Countries who do not have such
a pool of volunteers available to them have chosen to use amateur actors as simulated
bereaved relatives.
nally, some countries have from the beginning sought financial support from
other sources. All countries hope that once EDHEP has become a regular part
of professional education programs the running costs of the EDHEP work-
shops will be funded from local budgets.
Evaluation of EDHEP
Since 1992, over 330 participants have attended sixteen international EDHEP
TTT courses held, either at Eurotransplant's home base in Leiden, or another
host country. By the end of 1995 EDHEP was running in over 33 countries in
Western Europe [figure 3], the Middle and Far East and Latin and South
America. National Working Groups from these countries confirm that EDHEP
adapts easily to all national legal, religious, cultural and educational needs.
The program generates a more favorable attitude among critical staff to organ
donation, teaches more confident communication, stimulates national and
international professional collaboration and increases donor referral. Partici-
pants in the EDHEP workshops report that as a result they feel more confident
in their ability to talk with the bereaved and are more willing to do so.
Countries operating in a "presumed consent" system have also found the
major elements of the EDHEP workshop very relevant. Communication skills
are always needed when informing a bereaved family of the intention to
remove organs from a deceased loved one. Specific evaluations of 163
participants in pilot programs in Israel show an increase in knowledge on brain
death criteria, the law, the supposed negative position of the Jewish religion
in organ donation and the criteria for donation. These data also showed a
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Figure 3. European Donor Hospital Education Programme 1995.
significant improvement in participants' ability and willingness to approach
bereaved relatives for organ donation [figure 4]. Results from Japan show that
95% of doctors and 92% of nurses felt they had learned how to better
communicate with the bereaved and 90% and 88% respectively felt that
EDHEP was a useful educational tool [figure 5]. A one year controlled research
project of matched professionals has been carried out in the Netherlands. Both
groups were tested two weeks before the experimental group participated in
an EDHEP workshop. Both groups were retested at two weeks and six months
following the experimental group's participation in the workshop. The results
show an increase in knowledge of the experimental group on grief reactions,
communication skills and donation procedures. In addition, participants show
an increase in self-confidence in dealing with the bereaved. The experimental
group demonstrated a reduction in the perceived difficulty in requesting
donation and at six months follow up had made more donation requests that
the control group [figure 6]. All EDHEP participants rated the contribution of
EDHEP to their current practice positively. EDHEP seems to have a positive
effect on current practice in general not only relating to the care of the
bereaved and donation procedures, but also to working together as a team
[figure 7]. A controlled evaluation by the Universities of Liverpool and Maas-
tricht is underway that will, in addition to the above, analyze relatives'
satisfaction in the professional care they receive.
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Figure 4. EDHEP-evaluation of participants knowledge: (Source: Dr Pierre Singer, Director ICU,
Beilinson Medical Centre. Peta-Tikva, Israel.)
Do you fh/nfr you /earned how fo commun/cafe w/fh grieving fam/7/es?
Doctors Nurses
• yes
95.0% 92.0 %
-5.0% 8.0%
/s fhis programme usefu/ in your woricp/ace?
I I yes
90.0% 88.0 %
10.0%
Doctors Nurses
Figure 5. Pilot evaluations of EDHEP Kobe, Inuyama, Fukuoka: Japan: (Source: Ushida et al.
Development and assessment of methods to educate medical professionals and increase organ
transplantation in different prefectures. Japan.)
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Figure 6. Effect of EDHEP on participants self-confidence: the Netherlands. (Source: Blok GA
et al. Effect of the European Donor Hospital Education Programme, University of Maastricht,
the Netherlands.)
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Figure 7. Effect of EDHEP on current practice: the Netherlands. (Source: : Blok GA et al. Effect
of the European Donor Hospital Education Programme, University of Maastricht, the Nether-
lands.)
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Introduction
Improvements in standards of health, advances in medical therapies and
legislation on driving, health, and safety at work have all been successful in
saving young lives. However, coupled with the increased number of patients
registered on transplant waiting lists, such improvements may have added to
a world-wide shortage of donor organs and underline the importance that all
potential donors in Intensive Care Units (ICUs) are identified and families are
given the option to consider organ donation.
Since the 1970's, many countries have introduced initiatives to increase
organ donation. These include legislation, publicity campaigns, distribution of
donor cards, appointment of transplant co-ordinators (TCs), introduction of
donor protocols in hospitals, reimbursement of procurement costs, donor
registries, review of donor referral procedures, and educational programs.
Although these isolated initiatives may help to increase organ donation initially
non have been sufficient to make a sustained impact on the supply of donor
organs [1]. Only the introduction of specifically trained staff responsible for
organ donation, working in the hospitals at the "grass roots", has proven to be
consistently effective [2]. Estimates are that the average hospital misses
about one third of its potential for organ donation mainly because not all
donors are identified and many families are not presented with the option of
donation [3-7].
This continued shortfall in organ donors has led to the development of a variety
of different national [8] and state [9] initiatives to increase organ donation.
Those institutions tasked with organ procurement have been placed under
increasing pressure to improve their performance [10,11]. This in turn has led
to a major evaluation of the processes of organ procurement [12] and
allocation [13].
Donor Action (DA) is the result of collaboration between three organizations.
Eurotransplant International Foundation (the Netherlands), has spearheaded
the European Donor Hospital Education Program (EDHEP), an initiative to
provide health professionals with the communication skills to break bad news
and present the option of organ donation, now used in many countries
throughout the world [14,15]. Organizaciön National de Trasplantes (Spain)
has been particularly successful in increasing organ donation rates in Spain
through support programs for hospital-based TCs as responsible for the
overall donation process [16,17]. The Partnership for Organ Donation (United
States), in collaboration with Harvard University, has developed methodolo-
gies to assess the donation potential of ICUs [6,18]. These organizations
agreed to pool their expertise on an initiative to help hospitals increase their
donation rates through improved donation practices. DA takes a systematic
approach toward achieving quality assurance in donation. Experience in
Europe and the US indicates that a consistent hospital protocol built on multi-
disciplinary consensus can lead to a significant increase in donations [18-20].
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Such a protocol supports teamwork toward a common goal: to identify all
potential donors and provide optimal care for families.
The program is designed to help hospitals develop the improved donation
practices that are tailored to meet the identified needs of the ICU. DA aims to
streamline the roles and responsibilities of professional staff involved in the
donation process and focus responsibility on dedicated and trained individu-
als. The program provides a comprehensive package of tools, resources, and
guidelines to help an ICU determine its potential for donation, develop
appropriate donation protocols, and establish a team with clearly defined roles
and responsibilities in donation. In addition, it allows targeted and consistent
education and performance monitoring systems.
This article describes in detail the methodology employed by DA and reports
the results of its introduction into pilot hospitals with a two-year follow up.
Program design and methodology
Local implementation requires a multi-disciplinary, hospital-based team to
assess the current situation in organ donation and identify specific areas for
improvement and staff educational needs, then to put in place the appropriate-
ly adapted DA Core Program Modules. These modules correspond to the five
major steps in the donation process and are used to effect changes in one or
more specific areas of the process: donor identification, donor referral, family
care and communication, donor organ maintenance and retrieval [figure 1].
Implementation of DA is divided into several phases: 1. gaining hospital
support, 2. performing the diagnostic review, 3. program tailoring, 4. introduc-
ing the core program module(s), 5. monitoring and evaluating progress and 6.
program management.
1. Gaining hospital support
The introduction of DA into a hospital can only be successfully achieved with
the support of the senior hospital staff. Such a group can form the basis of a
permanent DA committee. The DA committee is a hospital-based, multi-
Figure 1
The Critical Donation Pathway DA Program Modules
Severe brain damage
Identify potential donor
Diagnose brain death
Refer potential donor to TC
Present option for donation
Maintain organ viability
Retrieve organs
Donor defect/on
Donor referra/
Fam/7y care and Commun/caf/on
Donor ma/nfenance
Organ refr/eva/
Five Donor Action Program Modules match the Critical Donation Pathway. The modules provides concepts
and examples of corrective measures that correspond to the critical steps in the donation process and come
as a "tool kit" for daily use in ICUs. The modules can be used alone or in any combination according to specific
identified needs.
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disciplinary team of senior staff committed to improving donation practices
and is well placed to inform appropriate colleagues about DA and clarify its
relevance in the workplace. The committee can give authority to the hospital's
efforts to ensure that all potential donors are identified and referred to the
procurement transplant coordinator (PTC)/organ procurement organizations
(OPOs), all families are approached in a caring and sensitive manner, and an
appropriate "quality" donation protocol is introduced. The DA committee acts
as custodian of the program and helps gain ICU support for the project. This
Committee also supervises the Diagnostic Review and, following analysis of
the data, helps identify areas for improvement, gain support for any recom-
mendations for improvement and, assign specific staff roles and responsibil-
ities in the donation process. A critical appointment is a DA Link(s), probably
a well-respected member of the ICU staff who can serve as the hospital's focal
point/in-house coordinator for donation. Such an appointment can focus
responsibility for the donation process proactively and independently of the
transplant team and establish an in-hospital partner for the TC. The program
materials include guidelines on establishing an official DA Committee and
information and presentation packages to help the hospital and ICU staff
understand the potential value of DA within their own environment.
2. The diagnostic review
The Diagnostic Review provides baseline information on an ICU's donation
performance and has three components: a Medical Record Review (MRR), a
Hospital Attitudes Survey (HAS), and a system database to analyze and report
on the findings.
D/\ sysfem database
A software package has been developed to analyze and report on the findings
from the MRR and HAS. This relational database can be installed on any PC-
based computer. The system features user-friendly screens for entering
hospital data and a series of push-button reports that retrieve and analyze the
data according to several predefined formats: raw figures, aggregated syn-
thetic figures and graphs. Since the DA System is based on a Microsoft (MS)
Access database, data stored in the system can also be retrieved and
analyzed using software packages such as MS Access or Excel. When
analyzing, the MRR users can set the upper age limit for potential organ
donation according to local criteria or, exclude or include non-ventilated cases
in the overall outcomes of potential donors if users wish to track the potential
for non-heartbeating tissue and/or organ donation.
The tools provided are the Database System on diskettes or CD-ROM and a
Technical Manual, which provides detailed instruction how to install and use
the database functions.
This validated computer-based analytical tool has been developed to measure
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gaps between potential and actual donors, indicating when and where in the
process potential donors are missed. While the program provides simple push-
button reporting systems, it also provides for detailed and sophisticated
analysis of the data both aggregated and by individual ICU. For example,
cause of death by ICU, cause of death of patients determined to be brain dead,
refusal rates before or following confirmation of brain death, cases with
documented signs of brain death but treatment was withdrawn, cases deter-
mined to be brain dead where families were not presented with the option for
donation, reasons for exclusion of brain dead cases as potential donors,
conversion rate of potential donors to actual donors, and the rate of organ
recovery can be accessed [table 1].
Table 1
Algorithm tor Classifying Potential Donor Outcomes
Donor Identification Process
Referral to TC, potential donor cases
organs: tissues: organs/tissues
Consent and Donation, potential donor cases
Legend: ^. Ideal protocol (organi/tbiii«}
— . . •>. Potiible alternative protocol (ihm«)
BD: Biain Death
NMS: Not medically suiubtc Outcome
MJUL. Copyright 04/1999
A retrospective MRR establishes a baseline against which to monitor improve-
ments. Success relies on co-operation and support from the ICU Directors and
the hospital Medical Records department to identify and retrieve relevant
medical notes.
a/gor/Mm
The MRR algorithm upon which the database is founded follows three essen-
tial elements for potential donors, identification on clinical evidence, referral to
the appropriate agency, and the consent and donation process, leading to a
predefined outcome as defined in the MRR "key" definitions.
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1. Identification of potential donors on clinical evidence starts with all cases
where the cause of death and/or concurrent disease was not a known
contraindication to organ donation [table 1]. Medically unsuitable cases,
non-ventilated cases (see DA system database above), cases where no
signs of brain death were documented, and cases where signs of brain
death were documented but brain death was not diagnosed are analyzed
by specific pathways. Cases where brain death was diagnosed are directed
to the consent and donation pathway. A further pathway tracking potential
tissue donors leads all medically suitable cases to the consent and
donation algorithm [table 1].
2. The referral section records the number of cases referred to the TC/OPO
as potential organ, tissue, or organ and tissue donors.
3. The consent and donation pathway records evidence on the number of
potential donors who carried a donor card or had otherwise recorded their
wishes to donate or not to donate, the number of families of potential donors
who were not available or were not approached, the number of families
approached with the option for donation and the number who objected , the
number of cases not released for donation by the coroner/judicial author-
ities and the number of families who did not object to organ donation.
Finally, the pathway records the number of donations by category and the
number of organs not retrieved even when there was no objection from the
family. The outcomes of approaches to families of potential donors are
automatically calculated as a percentage of all potential donors and as a
percentage of the actual number of approaches.
The tools provided in the MRR kit include guidelines on conducting the review
and data analysis, MRR forms, the MRR algorithm for classifying potential
donors and "key definitions" on the review's methodology and outcomes. In
addition, standard references are provided on the Glasgow Coma Scale, the
definition of brain death [table 2] and exclusion criteria for organ donation
[table 3].
The HAS is a simple, anonymous questionnaire administered to critical care
staff in units undergoing MRR to assess self-reported attitudes and knowledge
about donation and transplantation, involvement, skills/self-confidence in
donation-related activities and support provided in the donation process.
Finally, ICU staff are asked how much education they have received on
donation-related matters and how much more education they feel they need,
in what format, and the most convenient time of day. The process relies on co-
operation and support from the ICU medical and nursing directors, who need
to be well informed about the DA program, the purpose of the HAS, and its
relevance to the ICU staff. For a valid assessment of staff attitudes a
questionnaire return rate of more than 60% is a minimum requirement. It is
therefore worthwhile to invest time in holding informal seminars and provide
supplementary literature about DA before starting the HAS. Experience has
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Table 2
International brain death definition
Definition for "consistent with brain death"
1. Documentation of the following pre-existing conditions:
a. Known mechanism of injury
b. Absence of toxic CNS depression
c. Absence of metabolic CNS depression (i.e. severe hypothermia)
2. Documentation of at least one of the following categories (a. and/or b.)
consistent with brain death:
a. Clinical findings including 5 of the following 6
(may or may not be documented in one note)
ii. Pupillary reflex - negative
iii. Corneal reflex - negative
iv. Oculocephalic reflex - negative
v. Oculovestibular reflex - negative
vi. Gag or cough reflex - negative
b. One of the following studies
i. Cerebral blood flow studies
ii. EEG
iii. Other
3. No documentation of conditions inconsistent with brain death.
Reference: definition based on "Guidelines for the determination of Death".
JAMA 1981: 2462184-2186
Table 3
Absolute Contra-indication to Organ Donation:
• Active tuberculosis
• Human Immunodeficiency Virus (HIV) - infection or positive serological or viral
culture findings
• Jakob-Creutzfeldt disease
• Viral septicaemia
• Extra-cerebral malignancy or > 5 year history of treated malignancy
Relative Contra-indications to Organ Donation:
• Hepatitis C
• Hepatitis B surface antigen fun/ess organs are to 6e used for a Hepat/tfs S surface
anf/gen posrt/Ve paf/enty
• Extreme immaturity
• Connective tissue disease
• Agranulocytosis
• Aplastic anaemia
• Hemophilia
In all cases a careful examination should be made of the past medical and social history
and the current medical situation.
shown that when ICU staff take ownership of the distribution and collection of
the questionnaires, a higher response rate is achieved. Once the HAS forms
are collected, the data are entered into the database. When reviewed with the
MRR, the HAS database reports create a profile of the unit's donation
practices.
The tools provided in the HAS kit include guidelines on conducting the survey
and data analysis, HAS questionnaires, and an ICU sampling plan.
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3. Program tailoring
Program tailoring is the bridge between analysis of the results of the Diagnos-
tic Review and implementation of the DA Core Program in the ICU. It provides
a way to adapt the program to meet the special needs of an ICU based on the
assessment of existing strengths and weaknesses provided by the results of
the MRR and HAS analysis. The tailoring process can be broken down into four
steps.
Determ/n/ng Me potenf/a/ for donaf/on fftrougft
The database allocates an outcome for each medical record entered into the
system. It is therefore possible to use the database reports to evaluate the
number of cases unsuitable for donation as a percentage of the total number
of charts reviewed, the number of potential donors as a percentage of the
medically suitable cases, and the number of actual donors as a percentage of
the potential. Finally, the database reports the reasons for and number of
failed donations as a percentage of the medically suitable cases.
>Ana/yz/ng fhe HAS
Using the database reports, assess staff attitudes, knowledge, self-confi-
dence, satisfaction, and educational needs in the donation process.
areas for /mprovemerrt
Make correlations between the DA System MRR and HAS reports and
prioritize areas for improvement in the donation process: donor detection,
donor referral, family care and communication, donor maintenance, and organ
retrieval.
Cusfom/z/ng fr/e "Core" Program Modu/es fo fir /denf/rVed needs
Match the Diagnostic Review results to the Modules, create an action plan,
adapt and introduce the appropriate modules to the ICU, and implement the
improvement program.
4. Introducing the Core Program modules
Factors influencing donor identification and management success have been
identified as the following: a specific point of potential donor identification,
established protocols for declaring brain death, specific points of contact with
a PTC/OPO, communication with the family of potential donors, management
policies, monitoring systems and role definition and acceptance of responsi-
bilities. The Core Program provides concepts and examples of corrective
measures in the form of five modules that follow the donation process and
come as a "tool kit" for daily use in ICU. The modules can be used alone or in
any combination.
Donor detecf/on
The first step toward building an effective donation protocol. The goals in
donor detection are to create a new or improved detection protocol that
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identifies all potential donors. Tools included in the module include sample
protocols to establish a starting point to monitor potential donors and define
the role of the DA Link and when the DA Link becomes involved in the donation
process. A Medical Tracking Tool is used to record all relevant clinical
information.. The DA Link initiates the tracking tool at the pre-determined
point; the data can be used when informing the TC of a potential donor and can
be used by the PTC/OPO on arrival in ICU. The Medical Tracking Tool is
included in all program modules.
Donor referra/
The goals in donor referral are to refer all potential donors to the right person
at the right time and with all the appropriate information. Tools included in the
module include sample protocols to establish when the PTC/OPO becomes
actively involved in the process, who will convey the information to the PTC/
OPO and what role the PTC/OPO will take.
Fam/7y care and commtvn/caf/on
The goals in this module are to communicate sensitively and to identify the
right people to communicate with the family, separating the communication of
brain death from presenting the option for donation. Tools included in the
Family Care and Communication module include sample protocols and guide-
lines to help communicate regular and consistent information in a sensitive
and timely manner and a Communication Tracking Tool. This tool is used by
the DA Link to follow information given to the family and record the family's
understanding of events. The tool is initiated by the DA Link following a
diagnosis of severe brain damage and used throughout the donation process.
Ma/nfenance moc/iv/e
The goals are to achieve optimal clinical care in donor organ management.
The module provides sample protocols to maintain optimal organ function in
the potential organ donor.
Organ refr/'ei/a/
The goals in the organ retrieval module are to establish optimal hospital
practices in organ and tissue retrieval. Feedback to hospital staff and donor
families is the final step in building a total donation protocol.
Practical training workshops are included in the donor detection, family care
and communication and maintenance modules.
5. Monitoring and evaluating progress
Implementation of DA in hospitals is an on-going process that does not happen
overnight. Like any process of change, the program involves an investment of
time, personnel, and resources on an institutional as well as an individual
level. A multi-disciplinary team, working steadily, may require as little as 6
months, or as much as one year or more to fully implement changes in practice.
Initially, the program will require an investment of time from DA Committee
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members and other key people in getting started, the diagnostic review phase,
establishing a donation infrastructure and the implementation of the appropri-
ate program modules. Time requirements will significantly decrease as the
improvement practices are put in place, streamlining the donation process.
Once the initial Diagnostic Review has been analyzed, performance targets
can be set. The DA system database is then used as a prospective monitoring
tool by immediately entering details of the patients who die in ICU and storing
the data for future analysis. Using tools provided in the Program Modules, data
is collected on an on-going basis to monitor progress.
6. National program management
In countries with highly centralized systems for donation, it is recommended
to convene a National Working Group. In countries with more decentralized
systems for donation, program management may represent a state, province,
region, organ procurement organization, hospital, or a group of hospitals. The
specific role of the Group is to facilitate and oversee the introduction of DA.
The Group can adapt the program materials to fit the national situation, appoint
and train Project Manager(s), and provide ongoing support for the program. In
addition, this Working Group can facilitate the collection of local, regional, and
national data on donation potential and practices where such information is
not yet available. The Project Manager can evaluate the current national/
regional donation protocols, introduce DA to hospitals, recruit members for the
hospital DA Committees, help train and support hospital personnel, and
monitor the effectiveness of the improvement program. In summary, national
implementation of DA requires a management structure, training in the
concept and use of the program, adaptation of the program materials for local
use, the support of suitable pilot hospitals and potentially, project managers to
oversee the application of the DA program.
Results
P//of Eva/uaf/ons
Between 1995 and 1997 international pilot evaluations of the DA Diagnostic
Review took place in ICUs in the Netherlands [2], Spain [2], the United
Kingdom [1] and Canada [6], Program tools, as described in the program
design and methodology section of this article, were used to conduct a 12- to
18-month retrospective review of deaths in the pilot ICUs. The ICU staffs were
asked to complete the HAS questionnaire. The DA System database was used
to analyze these data.
Aggregated data of the MRR results based on 579 medical records of patients
who had died in ICUs showed that 181 (31%) of the cases were medically
unsuitable for donation. In the remaining 398 (68%) cases there was no
obvious contraindication to donation [figure 2].
Of the total 579 cases, 220 (55%) were determined to be brain dead. One
hundred and eighteen (54%) of these patients died as a result of a cerebral
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Figure 2
vascular accident (CVA) and 68 (31%) as a result of a road traffic accident
(RTA) or other head trauma (OHT).The remaining 34 deaths (15%) broke down
as follows: 6 cases of anoxia second to cardiac arrest, 6 primary brain tumor
(PBT), 9 gunshot injuries, 5 asphyxia, and 8 "other" causes. Of these 220 brain
dead cases 50 (23%) were lost to donation following an objection from the
family and in another two cases, the coroner/judicial authorities refused to
release the body for donation. In 23 (10%) cases brain death was formally
diagnosed but the families were not given the option to consider donation. In
a further 2 cases the family was not available and organ donation did not take
place. Twenty (9%) potential donors became medically unsuitable for donation
at some stage of the process and were excluded from the potential donor
population. Organ donation was successfully achieved in 119 (54%) cases
determined to be brain dead, an overall conversion rate of brain dead suitable
potential donors to actual donors of 59%. Of these actual donors, 65 (55%)
died as a result of a CVA and in three of these cases, the organs were
determined to be unsuitable and tissues were donated. Forty-four (37%) of the
donors died as a result of RTA or OHT. Of the 6 cases of PBT, three came to
donation although in one case the organs were deemed to be unsuitable and
only tissues were donated. There were 5 "other" causes of death in the
donating group. Overall in this donor population, in only one case were organs
removed and not transplanted..
In 178 cases brain death was not diagnosed. This represented 45% of the
medically suitable cases and, of these, 35 (20%) never displayed signs of
brain death. In 53 (30%) cases, signs of brain death were documented and
medical treatment was reduced or withdrawn. The major cause of death in this
group was CVA (17 of 32). In 50 (28%) cases, brain death was well document-
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ed and the families were approached for organ donation before a formal
diagnosis of brain death. In all cases, consent was denied. In addition, in two
cases the coroner/judicial authorities were approached at an early stage and
refused to release the case for donation, again the major cause of death in this
group was CVA (30 of 58). In the final 35 (20%) cases signs of brain death were
documented in the medical notes, there was no documentation implying de-
escalation of medical care, and the relatives were not approached. The
inevitable outcome was cardiac arrest. Among this non-brain dead potential
donor population there were 5 tissue donors and in one case kidneys were also
taken and transplanted.
The major points of failure were not the same in all studied hospitals, but some
common trends emerged. Low rates of donor identification related to a lack of
identified individuals, who were responsible and accountable for organ dona-
tion. Rates of family refusal overall were not very high, although there were
significant differences between hospitals [figure 3]. However, the option for
donation was not even presented to families in 50% of the potential donor cases.
Medical Record Review
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Aggregated HAS data from 2129 critical care medical and nursing personnel
revealed consistently strong support for organ donation, but that many staff do
not feel comfortable when performing key tasks close to donation. Belief that
organ donation saves lives (97%), support for donation (94%) and a willing-
ness to donate one's own organs (79%) were high in all country samples.
Significant differences in belief were observed when respondents were asked
whether they agreed that organ donation helps families with their grief. The
Canadian respondents were more likely to agree (72%), with lower levels of
agreement in the United Kingdom (57%), Spain (47%), and the Netherlands
(28%). In all countries, average ratings of skills/confidence were highest for
comforting the family (70%) and notifying the transplant co-ordinator (60%),
with lower comfort reported regarding explaining brain death (44%), introduc-
ing organ donation (38%), and requesting organ donation (31%). Ratings
varied widely across countries, with UK respondents expressing the highest
level of self-reported confidence, and Spanish respondents the lowest levels.
For example, 77% of UK respondents reported themselves as skilled/comfort-
able with explaining brain death, versus 57% of Dutch respondents, 50% of
Canadian respondents, and 12% of Spanish respondents. Similar variations
were seen regarding requesting organ donation: United Kingdom 52%, the
Netherlands 40%, Canada 33% and Spain 13%, respectively [figure 4]. It is
noteworthy that the sense of staff preparedness was lowest in Spain. This may
reflect the degree to which role specialization in donation has been success-
fully integrated into hospital practice [17].
/mmed/afe, sftort-term and susfa/ned effecf
Of the 4 original pilot countries completing the MRR and HAS retrospective
diagnostic analysis, national re-evaluations of donation and transplant prac-
tices and modification or introduction of transplant legislation retarded imple-
mentation of the identified corrective modules in two countries (Canada and
the Netherlands). In the UK centers (expanded from the original pilot centers)
short- term follow-up data (6 months-one year) are available. Follow-up in the
original Spanish pilot centers now exceeds two years.
Immediate (6 months), short-term (one year) and sustained (two years) effects
of the DA program on donation rates can be demonstrated. Causes of death
in these donation populations were essentially the same as seen in the
retrospective review.
In the United Kingdom, three of 27 regional ICUs took part in the international
pilot evaluations. Following analysis of the Diagnostic Review data, corrective
measures based on guidelines and references provided in the DA Detection,
Maintenance, and the Family Care & Communication modules plus a series of
communication skills training courses were introduced into the pilot ICUs. In
addition, many of the measures were adopted in the other 24 regional ICUs.
A 122% increase in organ donation was achieved regionally in the 6 months
following the start of the Diagnostic Review compared to the same 6 months
in the previous year. One year after the initial introduction of DA, donation rates
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throughout the region settled at a 40% increase over the year before the
introduction of DA [21]. This compared with a 2% national decrease in the
same period.
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A sustained effect (two years) has been demonstrated in Spain, the pilot
country with the longest follow-up experience. The retrospective MRR in two
major ICUs showed that 21% of the cases reviewed were medically unsuitable
for organ donation. Of the medically suitable potential donor cases, 19% were
not identified. In 18% of cases consent was denied, 2% were missed following
an incorrect decision on suitability for donation by the ICU staff, and 2% of the
medically suitable cases did not come to donation because of organizational
problems. In 5% of the cases, despite aggressive medical care it was impos-
sible to maintain haemodynamic stability and cardiac arrest occurred before
donation could take place. A 44% conversion rate of potential to actual donors
was achieved. Following the Diagnostic Review and introduction of the DA
Donor Detection, Family Care and Communication and Donor Maintenance
Modules and associated practical training a 33% increase in donation rates
was sustained over two years. Analysis of MRR and HAS data two years after
the introduction of the program showed that despite a drop in donation
potential (4%), 98% of potential donors were now identified and no potential
donors were lost as a result of inadequate donor management or organization-
al problems. This represents a conversion rate of potential to actual donors of
65% [figure 5]. The ICU staff declared an important increase in confidence in
performing donation-related tasks [figure 6]. However, in these units there has
been no significant effect on the family refusal rate, which remains at 18%, and
professional training in interaction with the bereaved continues.
Number
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Discussion
Gaining support for quality improvements in donation depends on good
communication techniques, problem-solving skills and building support by
negotiating existing talent. Gaining support for DA in an ICUcan be led by local
PTC/OPO and other hospital "champions", for example, intensivists, nephrol-
ogists, and/or other key staff. DA regards organ/tissue donation as a medical
speciality in its own right and aims to place responsibility for management of
the donation process in the hands of specifically trained staff at the point of
donation.
The computerized retrospective MRR, combined with the HAS, have proved an
immensely powerful tool in identifying specific organ donation problems in
individual countries and individual ICUs. The initial prototype of this database
was complex; gathering detailed clinical results from every patient. Over the 5-
year development phase it became clear that while such physiological and
biochemical parameters were of academic and medial value, they were of little
assistance in providing answers to the fundamental questions being ad-
dressed. What is the potential for donation? How many potential donors are
"lost"? At what stage of the donation process are they "lost" and why? In
addition, the volume of information demanded was so great as to deter the
regular use of the database as both a retrospective and prospective monitoring
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tool. The program finally introduced has the unique advantage of being based
on a relational database; for example, links can be made between staff atti-
tudes and skills to donation failures such as family refusals. Thus, the reporting
mechanism will identify the major problem areas in the donation process
without any recourse to complicated, sophisticated, or analytical skills.
For those of a more enquiring nature, built-in features allow detailed interro-
gation of the relational database so that specific questions can be addressed.
For example, one might wish to know how many patients diagnosed with brain
tumors progressed to donation; in this study it was 50%. How many donors
were under 40 years of age and, of these, how many were female? How many
respondents by professional group support organ donation? In the United
States in particular, the detailed gathering of data from ICUs has become an
obligatory process. However, this highly sophisticated data banking process
should not be compared or confused with the simplistic yet focused aims of the
analytical tools developed by the DA Foundation.
While the underlying algorithm used in the MRR process is complex, the basic
principle on which it relies is simple. Was this individual who died in the ICU
medically suitable to be a donor, were they a donor and if not, why not? Within
this simplistic notion dwells many complexities and sub- divisions, for exam-
ple, tissue donors versus organ donors and organs taken from patients who
suffered a cardiac arrest in the ICU (there was one such case in our pilot
study). The database is hopefully robust enough to deal with all such idiosyn-
crasies, although the learning process continues thanks to feedback from the
many countries now adopting the DA program.
Undoubtedly the most difficult patient population, which the program must
reconcile, is those who are medically suitable for organ donation but no formal
declaration of brain death occurs. In the absence of any data to the contrary,
these are identified as potential donor cases. Essentially these patients fall
into three groups.
1. Those in which no evidence of brain death was recorded in the notes.
2. Those in which some evidence of brain death is recorded.
3. Those in which significant evidence of brain death was recorded but no
formal confirmation of brain death was performed.
While numbers in each group varied from ICU to ICU and from country to
country, all of these patient populations existed in all the pilot groups analyzed.
The fate of these patients was essentially the same, either cardiac arrest or
"de-escalation of treatment" resulting in cardiac arrest. It is not the remit of the
DA Foundation to comment on individual ICU practice. However, a relevant
observation from the data presented here is that of the 50 (28%) cases in the
"suitable but not brain dead" category whose relatives were approached with
organ donation, there was a 100% refusal rate. This is clearly a practice of
benefit to no one and should be discontinued [22].
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The retrospective data presented here identified 398 potential donors. More
detailed case reviews may well have identified anomalous in the suitability for
donation of some, in particular those in whom formal diagnosis of brain death
was never established. The fact remains, however, that these 398 potential
donors produced 119 brain-dead donors and 5 non-heartbeating donors, less
than one-third of the potential. Given the desperate need for organs within the
patient population with end-stage organ failure this represents a significant
loss of life, loss of quality of life, and excess expenditure of health care money.
The results of the DA program reported here point to a possible way of
correcting this problem.
The data from DA pilot hospitals showed that ICU's starting points and needs
differ. The pilot data identified a significant number of unrealized donors and
also suggested that there may be important differences in attitudes and
perceived skills/confidence across countries. The Diagnostic Review has
proved useful in identifying problem areas in the ICU donation process and
providing a baseline against which to monitor progress. The MRR can
effectively identify untapped donation potential and, when matched with the
HAS, can be used to customize the program to individual hospital require-
ments. There has been a lack of data about hospital staff attitudes and skills
to allow for comparison across national systems and to support the targeting
of specific strategies to the needs within different countries. The results
reported here show the feasibility of collecting and comparing data across
national systems. The pilot findings also suggest that there may be important
differences in attitudes and self-perceived skills/comfort across and within
countries. Although data are only available over two years, the results of the
effect of DA on donation rates from Spain, which already has the highest
donation rates in the world, are encouraging. Even in a country with a national
donation rate of more than 30 donors per million population, DA was able to
increase and sustain organ donation from the pilot ICUs by 33% and signifi-
cantly improve all ICU staffs' skills and confidence in donation related tasks.
While the program described above was designed with the primary motivation
of improving the donor recruitment rate from ICUs, one observation requires
specific comment. Analysis of the cause of death of potential donors showed
a high incidence of CVA (50%) compared to RTA or OHT (25%). This probably
reflects improvements in road safety, car design, crash helmets and safety at
work legislation. However, the implications of this observation are important.
As therapeutic measures to deal with hypertension improve, the overall
donation pool will decline. This makes it all the more important that programs
such as DA are in place which can successfully identify every potential donor
although a 100% recruitment rate is probably impossible.
Conclusion
Donor Action provides an opportunity for ICU staff to take control and actively
contribute, where necessary, to changes in donation practices and create
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appropriate education strategies within their own environment. The introduc-
tion of the DA program allows points of failure to be identified and corrected.
Implementation of DA can contribute to an increase in organ donation rates by
up to 33%, sustained over two years. Since 1996, critical care and transplant
professionals from over 14 countries have attended specifically designed DA
training courses. These courses not only familiarize participants with the
program's aims, objectives and materials but also includes workshops dealing
with the many skills required when introducing change in the difficult area of
organ donation. In addition to the pilot countries (Canada, Spain, the Nether-
lands, and the United Kingdom), hospitals in Australia, Belgium, Finland,
France, Germany, Hungary, Italy, Poland and Switzerland are now at various
stages of implementing the program nationally. These countries have begun
to see a similar early DA effect with a 30%-100% immediate increase in organ
donation.
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Introduction
Transplantation provides benefits to society as a whole as well as to the
individuals who receive transplants. It is often the most cost-effective form of
treatment for end stage disease patients and offers the opportunity for patients
disabled by illness to play a fuller and more active role in society, thus reducing
the costs of healthcare and social care.
However, this form of treatment is limited by the availability of human organs
suitable for transplant. In part, the shortage is the result of the success of
transplantation and the consequent increase in potential transplant recipients.
Changes in donor demographics also contribute to persistently low numbers
of donor organs [1]. The ideal donor is someone aged between 16 and 45, who
died as a result of cerebral trauma probably caused by a road traffic accident.
However, this profile does not fit the average donor. Potential donors these
days are more likely to be older than in previous years and are more likely to
have died following a stroke than cerebral trauma. In addition, graft survival
rates for organs from these donors are significantly worse than from other
donors [1,2,3,4,5].
In addition, as the population ages, more and more older patients are entered
on to transplant waiting lists, thus increasing pressure on transplant pro-
grammes [table 1]. If all potential transplant recipients are to be treated in an
equitable way, there is no room for discrimination on the grounds of age or
social worth, although most clinicians would probably prefer to allocate organs
to those with the longest potential lifespan [6,7]. Thus, the transplant commu-
nity, which is under a moral obligation to make the best possible use of donated
organs, is faced with a dilemma: how to balance the needs of the potential
recipient with the need to allocate organs fairly [6].
Table 1: More elderly kidney transplant recipients on the Eurotransplant waiting list as per
December 31.
Age group (N=)
0-56
>56
1996
10855
76%
24%
1997
11165
73%
27%
1998
11789
69%
31%
1999
12089
68%
32%
Chi - square test p < 0.0001
In this article we consider one approach to this dilemma - expansion of the
donor pool - that is currently being investigated by Eurotransplant.
Organ allocation
In simple terms, Eurotransplant attempts to identify the best recipient for each
available donor organ (table 2). In reality, this decision is not that simple and
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a balance must be achieved between optimal use of all available organs,
including those from marginal donors such as the elderly and optimal life
expectancy of all transplant candidates. In the day-to-day reality of organ
allocation and in the face of donor shortages, this can mean achieving maximal
outcome under marginal conditions.
Table 2
Eurotransplant aims to:
• Achieve optimal use of available donor organs and tissues
• Secure a transparent and objective selection system based on medical criteria
• Assess the importance of factors that have the greatest influence on transplant results
• Support donor procurement to increase the supply of donor organs and tissues
• Further improve the results of transplantation through scientific research
• Promote, support, and coordinate organ transplantation in the broadest sense of the term
Allocation algorithms that take into account factors such as age, HLA match,
waiting time, clinical urgency, and so on have been developed using computer
models based on sound outcome data and scientific judgment. These algo-
rithms enable difficult allocation decisions to be made efficiently and without
delay to the transplant process [8].
Such allocation algorithms are, by necessity, not set in stone. Rather, they are
flexible schemes that can be altered to accommodate, for example, changes
in donor or recipient profiles and the latest outcome data. The structure of
Eurotransplant and its decision-making process enables adaptations in the
algorithm to be based on scientific data. Each organ-specific advisory commit-
tee wishing to change an algorithm can develop a recommendation to the
Eurotransplant board. The board members, like advisory committee members
are democratically elected, make the final decision to accept or refuse the
proposed change to the algorithm.
Expanding the donor pool
Thanks to fewer road traffic accidents, and improved intensive care facilities,
donors are more likely to have died as the result of a stroke rather than cerebral
trauma [1], hence the donor pool has changed qualitatively. In addition, the
transplant community is faced with an increasing donor shortage. Therefor,
ways to expand the donor pool have been sought and the reasons for rejecting
donors have come under close scrutiny. The worldwide trend is now to identify
sub-optimal donor populations, such as donors aged over 65 years
[3,4,5,9,10] or to introduce new initiatives such as the use of asystolic, or non-
heart beating, donors [11]. In the latter protocol organs are procured when the
heart -and thus the circulation- of the donor has come to a standstill. Kootstra
et al have greatly contributed to widen the acceptance of this new approach,
which -in fact- is the reinstitution of an old practice.
Before the concept of brain death became sufficiently accepted, asystolic
donors were the only source of organs. Recent publications revealed that
transplant survival with kidneys from non-heart beating donors was similar to
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that of transplants with kidneys from heart beating donors [12]. These encour-
aging results will undoubtedly lead to an increased number of transplant
centers introducing a non-heart beating protocol. The potential contribution of
this category of donors to the pool remains subject of debate, but is considered
to be substantial [13,14].
Eurotransplant is currently investigating the possibility of using organs from
expanded-criteria donors, in particular kidneys from donors aged over 65
years [15].
Until recently, it was accepted wisdom that as organs lose functional capacity
with age, organs from older donors would not be suitable for transplant.
However, studies now suggest that the chronological age of a donor does not
necessarily give an indication of the condition of that person's organs.
Provided that transplant conditions are optimized, organs from older donors
can survive as long as organsfrom other donors [5,10,16,17]. Moreover, while
a kidney that is functioning at less than its peak physiological capacity may not
be the best solution for a young patient on dialysis, it may be suitable for an
older patient with a shorter life expectancy.
A study carried out at Eurotransplant demonstrated that although kidneys from
older donors (over 55 years of age) produced lower graft survival rates at one
year than those from donors aged 6-55 (83% versus 90%) the difference did
not reach statistical significance until three years post-transplant (85% versus
74%).
Improvements in immunosuppression and organ preservation techniques in
recent years have also increased the chances of success for such transplants.
Studies in the USA and Spain demonstrate that while kidney transplants from
older people do carry a greater risk of reduced survival and poorer renal
function than those from younger donors, excellent outcome can be achieved
with a combination of careful donor and recipient selection, good surgical and
organ preservation techniques and, if necessary, transplant of both donor
kidneys into a single recipient [3,4,10].
Eurotransplant Senior Programme
The Eurotransplant Senior or 'old for old' Programme (ESP) is a natural
response to the universal trend extending the donor criteria. The programme
is currently undergoing evaluation in a pilot programme that began in January
1999. It aims to:
1. achieve more efficient use of kidneys from elderly donors
2. offer transplantation in elderly patients
The programme is restricted to:
• donors and recipients aged 65 years or older
• first transplants only
• only recipients who are non-immunized at the time of match
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The rationale for the recipient age restriction is that a kidney graft that outlives
the recipient is considered a success. If donor organs are physiologically
slightly sub-optimal, as is more likely with older donors, the graft has a greater
chance of surviving an older than a younger recipient. In addition, a prerequi-
site of the study is to reduce the cold ischaemia time as much as possible to
maximize the outcome in these recipients.
Only preliminary results from ESP are available. So far, of the 521 kidneys
included in the study, 403 were transplanted into recipients aged over 65
years. When compared with 118 non-ESP recipients, the cold-ischaemia time
was significantly less (11,27 hours compared with 18,10 hours in the non-ESP
group; p<0.0001). While it is too soon to draw conclusions about kidney
function, graft survival and patient survival, it is hoped that by optimizing
transplant conditions, such as patient profiles and cold ischaemia time,
outcome for recipients will be maximized.
If the programme is successful, the kidney allocation algorithm will be updated
to accommodate the new data and consequently, increase the donor pool avail-
able in the Eurotransplant region. Moreover, future studies will, undoubtedly,
consider the possibility of transplanting kidneys from old donors into younger
patients, as such transplants have already produced good results [3,4].
With programmes such as ESP, elderly patients will have a more equitable
chance of transplantation. In the past, elderly recipients were omitted from
waiting lists because of the shortage of organs and because of their increased
vulnerability to perioperate complications with consequently lower success
rates. [16]. The ESP program not only offers these patients a chance of
receiving a transplant, but also allows for the best possible transplant condi-
tions.
Conclusion
The continuing shortage of human donor organs has forced the transplant
community to look carefully at the restrictions previously placed on potential
donors. In addition, they have also been forced to check the validity of these
restrictions. The use of kidneys from elderly donors was thought to be an
option with a sub-optimal outcome. Yet, the evidence suggests that kidneys
from older donors, even those with a slightly reduced functional capacity,
appear to do well in both older and younger patients [3,4,5,10]. It therefore
seems likely that other factors, such as those relating to the recipient, may be
more influential on final outcome than donor kidney quality alone. Neverthe-
less, outcome from transplants in older people should be optimized, for
example, by reducing cold ischaemia time and/or by using a double kidney
transplant [18,19].
However, as the clinical needs of patients must be constantly weighed against
the need to allocate organs in a just way, restrictions must be lifted with caution
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and only on the basis of sound scientific research. The decision to use kidneys
from donors aged 65 years or older may increase the pool of donors, but it may
also increase risk for individual patients.
Allocation algorithms employed by organ exchange organizations such as
Eurotransplant need to be updated regularly to take into account develop-
ments such as the use of sub-optimal donor organs. If they are not adapted,
organs will not be allocated in the fairest possible way. Even so, no single
allocation algorithm will be accepted by the entire transplant community and
there will always be objections to the criteria on which they are based.
Objections are inevitable but, within a democratic system, they can be
minimized or overcome.
Eurotransplant has responded to the continuing shortage of organ donors and
the changing characteristics of donors, by adapting its kidney allocation
algorithm to include donors aged 65 years or older in ESP. Preliminary data
from ESP in conjunction with data from other studies suggest that provided
transplant conditions are optimized and donor and recipient are carefully
selected, there is a good chance of maximizing outcome.
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Organ transplantation is a unique human enterprise that has no parallel in
nature, with the possible exception of pregnancy. An adequate supply of
cadaveric donor organs requires the active participation of members of a
community, either directly through their personal consent or indirectly through
the consent of their relatives.
The acceptance of solid organ transplantation as the treatment of choice for
end-stage organ failure by both the medical profession and patients has led to
an increased demand for transplantation. Just as with any other venture that
provides a desired product or service, transplantation is governed by the
market mechanism of supply and demand. However, it differs from other
ventures in that supply does not increase in line with demand and a price
mechanism is completely lacking.
As donor organs are a scarce resource, organ transplantation is directly
dependent upon the level of cooperation within a community and the number
of individuals willing to donate their organs. The success of organ transplan-
tation has resulted in a marked increase in the number of patients on waiting
lists for transplantation. Unfortunately, that expansion has not been matched
by the necessary increase in the supply of organ donors. In their attempts to
resolve that problem, organ exchange organizations (OEOs) have expanded
their aims to include activities associated with the procurement of donor
organs [1].
Donor organ shortages are not resolved by OEOs but by the members of the
communities they serve. Nevertheless, OEOs play a pivotal role in the
resolution of this problem. OEOs carry out publicity campaigns to inform
members of the public as well as healthcare professionals of the seriousness
of the problem. The general public must also be informed of the benefits of
transplantation; they must be willing to make altruistic decisions that affect
their loved ones. Such decisions are often difficult in the face of long-term
cultural traditions. Medical professionals must also remain alert to the possi-
bility of organ donation by terminally ill patients and be willing to request
permission for donation from relatives.
Many potential organ donors are treated in intensive care units (ICUs) and this
fact was the motivation for the establishment of the Donor Action Programme,
an international effort aimed at improving donation rates from patients in ICUs.
This quality assurance initiative uses core program modules that correspond
to each of the critical steps in the donation process. The aim is to customize
the donation process within each ICU and to provide intensivists with a
systematic method to improve donation rates [2].
OEOs also have a fundamental educational role, but educating the public and
healthcare professionals is a slow process that requires persistence. It also
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demands that OEOs constantly evaluate transplantations and identify reasons
for success or failure. Such information is essential in justifying any changes
in the operational policies of the allocation process. Improved transplantation
results lead to a reduction in the number of patients who require retransplan-
tation and, therefore, the size of the waiting list and length of waiting time.
Waiting time is especially important as appreciable numbers of patients
waiting for a transplant die before they are allocated donor organs.
Organ donors are normally classified into two main groups: cadaveric and
living. Road traffic accident victims are the one source of cadaveric donor
organs. These donors are usually younger than donors who have suffered a
fatal cerebrovascular accident, the largest source of cadaveric organ donors.
The decrease in road traffic fatalities, due to maximum speed reductions and
seat-belt regulations, has significantly reduced the number of high quality
donor organs. The acceptance of elderly donors over the past decade has
compensated for this decline, with a consequent increase in the proportion of
donors whose cause of death was a cerebrovascular accident [3].
Prior consent is required before an organ may be removed for use in
transplantation. Legislation in many countries recognizes two methods for
obtaining such consent. Under the system of 'presumed consent', which
operates in Belgium, Austria, and France, everyone is assumed to agree to
donation and a centralized computer database stores a record of individuals
who object to their organs being donated after their death. If such a record
cannot be found at the time of death, the organs maybe removed and used for
transplantation. In systems that use 'informed consent', for each individual
who has not recorded his or her informed consent to organ donation before
death, consent must be sought from the next of kin before organs can be
removed and used for transplantation.
The use of donor cards and central registration of donor information might
eventually help to improve donation rates but these measures are a long-term
investment as it can be many years before individuals become donors. The
short-term solution to this problem rests in the hands of medical professionals,
who must be constantly alert to the possibility of organ donation by their
terminally ill patients and be ready to inform the transplant coordinator of that
possibility. These professionals are also the logical people to request permis-
sion for donation from the patient's relatives, although they can be unwilling to
carry out this task. The European Donor Hospital Education Program (ED-
HEP) was set up in 1990 to counteract the lack of training and experience
within the medical profession in dealing with the bereaved and in requesting
organ donation [4]. The objective of the EDHEP is to improve understanding
among medical professionals of the various issues related to organ donation
and transplantation and to assist them in communicating effectively and
sensitively with bereaved family members. Transplant coordinators and local
liaison officers are available to assist in this task. Once permission has been
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given for donation, the transplantation team takes over and is, therefore, not
involved in the organ request procedure.
Further attempts to resolve the shortage of donor organs have led to the
acceptance of non-heart beating donors, donors older than the long-standing
limit of 55 years of age, and extended donor criteria (such as hepatitis ex-
positive donors), en-ö/oc transplants, domino hearts and livers, split liver
procedures, etc. [5]. Living donors are another source of organs for transplant.
These donors are usually related to the potential recipients, either genetically
or emotionally (spouses, partners, and friends). In some cultures, such as the
Middle East and Asia, this is the major form of donation [6].
There is a considerable degree of ethical uncertainty about the acceptability
of using organs from living-related donors for transplantation. It arises from the
uncertainty about whether or not the organs have been donated freely. Should
relatives of patients, whose organ failure has been the result of diseases that
have a strong genetic predisposition be accepted as donors? Does doing so
endanger the donor? The publication by Terasaki ef a/, which demonstrated
that graft survival rates using kidneys from spousal and living unrelated donors
are superior to those obtained with cadaveric donors, led to an increased use
of living donors in Eurotransplant [7] [figure 1]. The newest innovation in the
attempts to resolve the shortage of donor organs, however, involves the use
of non-directed donations. They are provided by living individuals who are
neither genetically nor emotionally related to the eventual recipient. This
approach has been followed only in a few centers and it is the subject of
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considerable ethical controversy. Such ethical dilemmas will naturally be
resolved when adequate numbers of unrelated, cadaveric donors become
available [8].
The continuing shortage of donor organs has led to the exploration of the
possibility of breeding genetically modified animals, such as pigs, to enable
their organs to be used in human transplantation. However, this is also
affected by ethical constraints and questions about animal rights that must be
resolved before xenotransplantation is taken seriously as an option for
resolving the persistent donor-organ shortage problem. The concern about
the potential biological hazard of transmitting foreign bacterial or viral patho-
gens to human recipients, whose immune response may be uncertain, espe-
cially as they receive immunosuppressive therapy after transplantation, must
also be resolved before this option receives further consideration [9).
Allocation policies are developed on the basis of utility, justice, and equity of
a procedure. The selective allocation of donor organs is an inevitable aspect
of transplantation that aims to allocate organs to the best recipients. There are
technical and ethical constraints on the definition of 'best recipient'. The
definition might be based on the patient's clinical urgency, age, waiting time,
size, degree of matching with the potential donor, number of previous trans-
plants, and so on. Donor factors might also contribute to the definition and thus
to the selection process. Should organs from older donors, with their reduced
physiological functional capacity [10,11], be allocated only to older recipients
with a relatively restricted life expectancy rather than to those with a longer
potential lifespan? Similarly, should organs from young donors be allocated-
preferentially to young recipients with a long life expectancy?
The admission of patients from immigrant populations to transplantation
waiting lists also confronts us with a controversial ethical dilemma. We cannot
refuse to register them but we might also expect their community to donate
organs. When patients come from countries whose genetic and cultural
backgrounds are markedly different from those of the host countries, the
probability of being allocated a well-matched donor organ might initially be
small. The chances rise only after the immigrant community has been ade-
quately educated about the transplantation process and motivated to partic-
ipate. The duration of this transition may be prolonged, especially if cultural
traditions do not approve of cadaveric organ donation.
An important technical constraint on organ allocation is relatedto HLA tissue
types, which must be matched between donors and recipients. This creates
an automatic selection bias, without which the graft could be rejected. The risk
of rejection can be reduced with immunosuppressants but the use of such
drugs confers serious additional risks, suchas the induction of malignant
tumors [12]. Matching, therefore, is not only a technical but also an ethical
problem.
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Such considerations and new initiatives to increase organ donation play a
key role in public and professional discussions of the organ shortage pro-
blem. Fortunately, most transplantation organizations, such as the Inter-
national Transplantation Society and Eurotransplant, have medical ethics
committees to supervise the actions of their members and to make sure
that their policies and practices do not violate acceptable ethical constraints.
In some countries, however, one class of serious ethical violations of
normal transplantation practices has developed: commercial activity in organ
donation and organ trafficking. Such activities are not sanctioned by the
international transplantation community to whom they seem abhorrent and
unethical [13].
A commercial donor pool usually consists of poor individuals, while the
recipient pool is wealthy, a clearly unethical situation. A central clearing
house for reports on such undesirable commercial practices - an Interna-
tional Donor Surveillance Committee - could be used to compile and distribute
reports of commercial activity in transplantation. Such reports would stimulate
the investigation of these practices and they would help to detect trends
in organ donation commerce. Publication of such reports would also help
to reduce the transient reduction in organ donation rates, which usually
follow the publication of stories of commercial malpractice in the media. The
desirability, structure, and advantages of such a committee was discussed
at the last meeting of the Transplantation Society in Rome (August 26, 2000)
and the Council endorsed the initiative of the establishment of such an
organization. It would be expected to function completely independently
of any transplantation-oriented organization, such asOEOsororgan procure-
ment organizations. The naming of the organization and the funding of
its activities awaits the decision of the international transplantation commu-
nity.
The efficiency of organ donor procurement is affected by the level of financial
support that governments and health insurers are willing to invest. Such levels
vary between countries. In Spain, for example, the Government has taken the
initiative to establish a sound reimbursement system for cadaveric organ
donation. This policy, together with a centralized education system, has
resulted in the highest level of organ donation in the world, as measured by the
number of donors per head of population [14]. Historically, the USA has also
been one of the leaders in this field. Several different initiatives have been
undertaken to increase organ donation, such as required-request [15]. The
geographic organization of organ donation programs through organ procure-
ment organizations and the high level of funding by the Government and health
insurers has also contributed to an increased number of organ donors in North
America. In contrast, the governments of Germany and the Netherlands have
reacted late to the need for legislation to promote organ donation. As a result,
we must wait to see if the new laws will lead to any improvement in the donor
situation in these countries.
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The shortage of donor organs is a direct result of the acceptance of transplan-
tation by the medical profession and by patients as the treatment of choice for
end-stage organ failure. The search for solutions for the persistent shortage
of donor organs requires not only the constant efforts of medical care and
scientific professionals but also the cooperation of the general public. Those
solutions must be sought on educational, logistical and technical levels.
Educational programs
OEOs must constantly inform the general public of the possibility of transplan-
tation, provide reports of its results and advances in the field and of the
importance of their registering as potential donors in the event of their demise.
Healthcare professionals must also be targeted by specific educational pro-
grams. Ideally, such programs should be part of professional training in
medical or nursing schools. Healthcare professionals should be informed
about the prerequisites for transplantation, specifically the timely reporting of
potential organ donors and the proper technique for communicating with
relatives to obtain permission for donation. Hospital staff should be aware of
their hospital s donation policy and how to contact the local transplant coordi-
nator, who will assist them in the early, critical stages of the donation process.
Education programs must be customized for each group of professionals. The
Donor Action Program is an example of such a specialized program. It is a
quality assurance program to increase donation rates in ICUs. Between 1995
and 2000, the Donor Action methodology has been introduced in pilot centers
in 17 countries. Although the implementation of the program is at different
stages in each country, sufficient data were available from 10 countries to
analyze the impact of the program on donor referral and donation rates.
Comparisons between one year before and one year after implementation of
the program shows an average and significant increase in donation rates of
51% (paired t-test: p=.0009) [figure 2].
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Logistical developments
The use of cadaveric donors and of living related donors was not sufficient to
adequately meet the demand for donor organs. The introduction of the practice
of multi-organ cadaveric donation helped reduce the magnitude of the shortage
but did not resolve it. Consequently, additional sources of donors had to be
found. One source has been derived by the acceptance of so-called expanded-
criteria donors. These donors are individuals in the lower and upper age
groups, with a history of diabetes or hypertension, are haemodynamically
unstable, have abnormal organ function, are non-heart beating (i.e. cardiopul-
monary ratherthan brain dead), are hepatitis B or C seropositive, have system-
ic infections, or who have a history of malignancy [16,17]. In some cases, the
use of dual kidneys from these sub-optimal donors, to compensate for their
physiological function, has been advocated, especially, for elderly patients.
Although the risks of such transplants are higher than those from other donors,
their use can be justified by the improvement in the length of life or the quality
of life of recipients as compared with, for example, life on haemodialysis.
The use of non-directed living donors is one of the latest innovations in the
search for donor organs. Those altruistic individuals are neither genetically
nor emotionally related to the potential recipients of their organs.
Technical innovations
These innovations for transplantation are provided by healthcare profession-
als and by the scientific community. They must continue to focus on prolonging
the functional life of transplanted organs. Since a rejected graft is a wasted
graft, the number of patients who must be returned to waiting lists for a re-
transplant should be avoided. The matching of donors and recipients should
be carried out so that the adverse effects of immunological factors, such as the
degree of HLA-mismatches and level of panel-reactive antibodies, as well as
of non-immunological factors, such as the age of the donors and the duration
of cold ischaemia, are minimized. Other factors should also be identified and,
if possible, neutralized [18].
Theoretically, xenografts could provide adequate numbers of donor organs for
transplantation. However, it is clear that xenotransplantation will take either a
very long time or, perhaps, may never be a real option because of the natural
immunological barrier to cross-species transplantation. That barrier may be
overcome eventually by the techniques of induced tolerance or organ-specific
tolerance. Nevertheless, the eventual biological hazards resulting from the
transfer of viruses from non-human species to human donors and, possibly to
human populations must be avoided at all costs. The cloning of solid organs
from human stem cells may be a more realistic option, but only in the long-
term. It will require many decades before it becomes a practical source. The
implantation of artificial, mechanical organs is a definite technical possibility
that is currently being explored. Each of these innovations might not represent
a long-term solution but, nevertheless, each must be explored.
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Finally, it is clear that the solution of the shortage of donor organs for
transplantation will require the constant, concerted effort, not only of OEOs
and members of the various healthcare organizations but also of governmen-
tal bodies, health insurance organizations, and of the general population. No
single approach will achieve the goal of a balance between supply and
demand of organs for transplantation. Experiences in Spain of support pro-
grams for hospital-based transplant coordinators, in Austria and Belgium of
presumed consent legislation, and in the USA of regional procurement organ-
izations, provide valuable experience which could lead to a more systematic
approach towards helping hospitals improve their donation practices. In
addition, new activities, such as expanding the donor pool, will contribute to
further increases in organ donation rates. Those efforts will generate many
new ethical questions that will continue to require our careful consideration.
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Some contemporary ethical considerations related to organ transplanta-
tion
With the increasing number of transplantable organs, as well as improvements
in transplantation results, has come a severe shortage of organ donors.
Consequently, new ethical dilemmas, related to the fair allocation of available
organs and the use of alternative sources of donor organs, are of growing
concern and are outlined in chapter 2. Establishing fair allocation priorities is
a serious problem in organ transplantation. Ethically, they should be defined
by society as a whole rather than exclusively by the medical profession.
Proposed solutions for the organ donor shortage, each with their unique
ethical constraints, include the use of related donors, partial organ transplan-
tation, cell transplantation using fetal tissue, and the use of animal organs
("xenotransplantation"). Commercial trading in donor organs must be regard-
ed as an unethical activity rather than an ethical dilemma since the donors are
motivated by monetary rather than by humanitarian reasons. These ethical
dilemmas could be largely avoided by an effective reduction in the severe
shortage of postmortal organ donations.
Commerce in transplantation
Commerce in transplantation is well known, if not well defined. Although, the
word commerce suggests an exchange of money, in reality it often simply
signifies a non-profit-making transaction. Nevertheless, money, and therefore
profit, may be involved in some human organ transactions, and the buying and
selling of organs for transplantation remains common in too many countries.
Clearly, if such transactions were allowed to continue only those who could
afford to pay would benefit. They would probably also lead to an increase in
the number of media horror stories. A number of such stories have appeared
in the past and are illustrated in chapter 3. Although they are rarely based on
hard evidence, they do influence politicians and, as a consequence, affect
legislation and the availability of organs for transplantation. They may also
diminish the willingness of the general public to become organ donors and
contribute to the persistent poor supply of organ donors. Organ exchange
organizations, such as Eurotransplant, have made many efforts to prevent
unethical transactions. Nevertheless, stories of such transactions continue to
appear and are unlikely to abate while there is a high demand and poor supply
of organs for transplantation. An international donor surveillance committee -
a clearing house for information on malpractice - could be one solution to the
problem as it would prevent doctors from taking part in unethical transplant
procedures.
Changing patterns in organ donation
Organ transplantation has become the treatment of choice for patients with
end-stage organ failure and its success has led to progressive increases in the
size of waiting lists over the past decade. Unfortunately, from 1990 to 1994, the
number of organ donors remained stable while the number of organs trans-
planted from these donors increased by only 10% as is described in chapter
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4. In view of the severity of the current organ shortage, elderly individuals are
increasingly being accepted as organ donors. The graft survival rate with
kidneys from donors older than 55 years is 5% lower than that with kidneys
from younger donors at one year and 9% lower at three years post-transplan-
tation. Graft survival is also significantly lower with organs from donors who die
from cerebrovascular accidents than it is with organs from donors whose
cause of death is cerebral trauma. The number of patients waiting for a non-
renal donor organ has increased rapidly in the past 5 years, and an increasing
number of donor kidneys are now being provided by multi-organ donors. The
favorable graft survival rate with multi-organ donor kidneys, which is signifi-
cantly better than that obtained with single organ donor kidneys, confirms their
suitability for renal transplantation.
Trends in organ donation
Renal and extrarenal transplant data were collected for seven geographical
regions for the period 1989-1996 and are given in chapter 5. In Western
Europe and North America the number of kidney donors increased by 926 and
2743, respectively. The total number of transplants also increased in both
regions by 3756 and 6936, respectively. Renal transplants accounted for
approximately 60% of the total number of transplants and, although the
number of renal transplants did not alter in Western Europe, the number rose
by 3055 in North America. Outside these regions the number of extrarenal
transplants was 3-18% of the total. The number of living kidney donors in North
America increased each year and was higher than the number recruited in
Western Europe (3389 versus 943 in 1996). With the exception of Eastern
Europe, where virtually no renal transplants were carried out using organs
from living donors, the number of living kidney donors rose in other regions:
for example, in Latin America, the proportion of living kidney donors rose from
29% in 1970-88 to 51% in 1995, and, in Asia, 90% of kidneys were donated
by living donors.
As the quality of cadaveric donor organs is often sub-optimal, the use of living
donors is likely to increase in both Western Europe and North America, but is
unlikely to become the most important source of organs in these regions.
A European perspective on organ procurement
A worldwide shortage of donor organs has led to the development of national
and international systems for organ procurement and allocation and are
described in chapter 6. These systems promote organ donation and ensure
fair distribution of available donor organs through a combination of legislation,
organ exchange organizations (OEOs), transplant coordinators, publicity
campaigns, donor cards, and professional training programs. The develop-
ment of national and international OEOs is central to this process because
they maintain waiting lists and allocate organs in the most appropriate way.
Most countries also employ transplant co-ordinators whose role involves
promoting links between transplant centers and intensive care units, estab-
lishing protocols for organ donation, and helping hospital staff deal with the
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sensitive issues involved in organ donation. An educational initiative, such as
the European Donor Hospital Education Programme developed by Eurotrans-
plant is now used in over 30 countries worldwide. The program aims to improve
professionals' understanding of the legal and ethical issues involved in
transplantation, to help them communicate effectively and sympathetically
with bereaved families, and to increase organ donation rates. Other initiatives
include programs such as the Donor Action Programme, which was set up by
professional organizations in the US and Europe aiming to help hospitals
establish tailor-made organ procurement policies to ensure that all potential
donors can be identified and reported and the needs of unfortunate families
can be met in a caring and sensitive manner.
EDHEP
EDHEP is a bold initiative designed to tackle the lack of training or experience
that exists within the medical profession in dealing with the bereaved and
requesting organ donation. Its primary function is to establish and monitor a
nationally appropriate education program throughout Europe that will teach
relevant medical staff to become confident, if not comfortable, in requesting
organ donation from distressed relatives. The outstanding international inter-
est in EDHEP displays almost universal concerns over the shortfall in donor
organs and the lack of communication skills training in medical and nursing
schools. There can be no doubt that the skills awareness workshop goes some
way towards meeting the current needs of professionals working in critical
care areas of hospitals. The long term goal of EDHEP is that these staff should
acquire a positive attitude towards the benefits of transplantation that will,
perhaps, help mitigate the distress of the relatives and increase the rate of
organ donation.
Donor Action
Donor Action (DA) is an international initiative that helps Intensive Care Units
(ICUs) improve donation and is further described in chapter 8. Existing best
practices from around the world have been incorporated into this quality
assurance program. Following a validated Diagnostic Review, areas of weak-
ness in donation practices are identified and the appropriate changes intro-
duced. Corrective measures have been developed in the form of five "Core"
Program Modules which correspond to critical steps in the donation process
and can be used together or alone according to specific identified needs.
Medical records review (MRR) and hospital attitude surveys (HAS) were
performed in 11 ICUs in Spain [2], the Netherlands [2], the United Kingdom [1]
and Canada [6]. Baseline data were gathered on the units potential for
donation, staff attitudes towards donation and, self-reported, skills/confidence
in performing a range of donation roles. Analysis of these data was used to
customize the program to individual ICU requirements. MRR data from 579
cases showed a 69% (398) potential for donation from which only 31% (124)
were realized. Detection and management failures (166;42%) and refusal to
donate (104; 26% ) were the major reasons for loss of potential donors. The
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HAS returns from staff (2129) showed consistently strong perceptions that
organ donation saves lives (97%). Support for donation (94%) and willingness
to donate their own organs (79%) were high in all country samples. Ratings of
skills/confidence were highest for comforting the family (70%), with much
lower comfort levels reported on explaining brain death (44%), introducing
organ donation (38%), and presenting a family with the option for donation
(31 %). Following introduction of the appropriate program modules a sustained
(two-year) effect of a 33% increase in donation rates is demonstrated. The
Donor Action HAS and MRR are useful tools in identifying problems within the
donation process and lead to the introduction of improvement strategies
integral to the Donor Action program that result in an increase in organ
donation.
Future trends in organ allocation
The continuing shortage of donor organs has forced the transplant community
to look carefully at the restrictions previously placed on potential donors. In
addition, they have also been forced to check the validity of these restrictions.
Alternative strategies are now being explored such as the usage of non-heart
beating donors, compromised donors, elderly donors, etc. In addition, new
surgical approaches such as the split-liver technique and en-bloc transplants
are being introduced. The use of kidneys from elderly donors was thought to
be an option with a sub-optimal outcome. Yet, the evidence suggests that
kidneys from older donors, even those with a slightly reduced functional
capacity, appear to do well in both older and younger patients.
Eurotransplant has responded to the continuing shortage of organ donors and
the changing characteristics of donors, by adapting its kidney allocation
algorithm to include donors aged 65 years or older in Eurotransplant Senior
Program (ESP). Preliminary data from ESP in conjunction with data from other
studies suggest that, provided transplant conditions are optimized and donor
and recipient are carefully selected, there is a good chance of maximizing
outcome as is illustrated in chapter 9.
However, as the clinical needs of patients must be constantly weighed against
the need to allocate organs in a just way, restrictions must be lifted with caution
and only on the basis of sound scientific research. For example, the decision
to use kidneys from donors aged 65 years or older may increase the pool of
donors, but it may also increase risk for individual patients. Therefore, the
allocation algorithms employed by organ exchange organizations must be
updated regularly to take into account developments such as the use of sub-
optimal donor organs. If they are not adapted, organs will not be allocated in
the fairest possible way.
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Enkele ethische overwegingen betreffende orgaantransplantatie
Doordat steeds meer Organen getransplanteerd kunnen worden alsmede door
de verbeterde transplantatieresultaten is er een groot tekort aan orgaando-
noren ontstaan. Nieuwe ethische dilemma's die daar het gevolg van zijn, zoals
de rechtvaardige toewijzing van organen en het aanwenden van alternatieve
bronnen voor donororganen, zijn redenen voor zorg. Deze worden besproken
in hoofdstuk 2. Het vaststellen van rechtvaardige prioriteiten bij de toewijzing
van organen is een groot probleem in de orgaantransplantatie. Vanuit ethisch
standpuntzoudit door de gehelesamenlevingbepaaldmoeten worden in plaats
van alleen door de medische beroepsgroep. leder voorstel om het tekort aan
orgaandonoren op te lossen, waaronder het gebruik van verwanten als donor,
gedeeltelijke orgaantransplantatie, celtransplantatie waarbij gebruik wordt
gemaakt van foetaal weefsel en het gebruik van dierlijke organen ("xenotrans-
plantatie"), heeft zijn specifieke ethische beperkingen. Handel in organen moet
gezien worden als een onethische activiteit in plaats van een ethisch dilemma,
omdat donoren dan handelen uit geldmotieven en niet uit humane overwegin-
gen. Deze dilemma's kunnen grotendeels vermeden worden door het grote
tekort aan postmortale orgaandonaties effectief terug te dringen.
Handel in organen
De handel in organen voor transplantatie is bekend, maar niet duidelijk
omschreven. Alhoewel het woord handel een overdracht van geld suggereert,
gaat het in werkelijkheid vaak om transacties waarbij geen winst gemaakt
wordt. Niettemin is er bij sommige transacties van menselijke organen sprake
van geld en dus van winst. Het kopen en verkopen van organen voor
transplantatiedoeleinden is nog steeds niet ongewoon in te veel landen.
Wanneer men dit soort praktijken toestaat, zal het duidelijk zijn dat deze alleen
ten goede komen aan diegenen die het zieh kunnen veroorloven. Het leidt
ongetwijfeld ook tot nog meer horrorverhalen in de media. Een aantal van die
verhalen uit het verleden wordt in hoofdstuk 3 beschreven. Hoewel ze zelden
gebaseerd zijn op harde bewijzen worden politici erdoor bei'nvloed, hetgeen
repercussies heeft op wetgeving en beschikbaarheid van transplantatieor-
ganen. Hierdoor kan ook de bereidheid van het publiek verminderen om
orgaandonor te worden, hetgeen bijdraagt tot een aanhoudend tekort aan
orgaandonoren. Orgaanuitwisselingsorganisaties, zoals Eurotransplant, heb-
ben veel moeite gedaan om onethische praktijken te voorkomen. Niettemin
blijven er verhalen over zulke transacties circuleren en het is onwaarschijnlijk
dat ze zullen verdwijnen zolang de vraag naar transplantatieorganen groot en
het aanbod klein is. Een internationale commissie van toezicht -een uitwis-
selingscentrum voor informatie over kwade praktijken- zou een oplossing voor
dit probleem kunnen zijn, omdat voorkomen wordt dat artsen meewerken aan
onethische transplantatieprocedures.
Veranderingen op het gebied van orgaandonaties
Orgaantransplantatie is de beste behandelingsoptie voor patienten die zieh in
het eindstadium van orgaanfunctiestoornissen bevinden. Het succes van
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transplantatie heeft in de afgelopen tien jaar geleid tot een progressieve
toename van de wachtlijsten. Helaas is tussen 1990 en 1994 het aantal
orgaandonoren constant gebleven terwijl het aantal getransplanteerde or-
ganen van die donoren slechts met 10% gestegen is. Deze ontwikkeling wordt
beschreven in hoofdstuk 4. Als gevolg van de omvang van het huidige
orgaantekort worden oudere mensen steeds vaker geaccepteerd als orgaan-
donor. Het overlevingspercentage van getransplanteerden met nieren van
donoren ouder dan 55 jaar is echter na een jaar 5% lager dan bij nieren van
jongere donoren en is drie jaar na de transplantatie zelfs 9% lager. Het
overlevingspercentage van getransplanteerden is ook duidelijk lager bij or-
ganen van donoren die aan een beroerte (CVA) zijn overleden dan bij organen
van donoren die zijn overleden aan een hersentrauma. Het aantal patienten
dat wacht op een donororgaan anders dan een nier is de afgelopen jaar
eveneens snel toegenomen. Als gevolg hiervan wordt een steeds groter aantal
donornieren nu verkregen door zogenaamde multi-orgaandonoren, d.w.z.
donoren die behalve nieren ook andere organen afstaan. Het gunstige over-
levingspercentage van getransplanteerden met nieren van een multi-orgaan-
donor, in vergelijking met patienten die nieren kregen van een donor die
slechts nieren doneert, bewijst dat die groep donoren zeer geschikt is voor
niertransplantaties.
Ontwikkelingen in orgaandonatie
Transplantatiegegevens over de periode 1989-1996 in zeven geografische
regio's in de wereld werden verzameld en worden in hoofdstuk 5 besproken. In
West-Europa en Noord-Amerika is het aantal nierdonoren in deze periode
gestegen met respectievelijk 926 en 2743. Het totale aantal transplantaties is
in beide gebieden gestegen met respectievelijk 3756 en 6936. Ongeveer 60%
van het totale aantal transplantaties betrof niertransplantaties. Terwijl het
aantal niertransplantaties in West-Europa vrijwel onveranderd bleef, is het
aantal in Noord-Amerika toegenomen met 3055. Buiten West-Europa en
Noord-Amerika omvatte het aantal "niet-nier" transplantaties slechts 3-18%
van het totale aantal. Het aantal levende nierdonoren in Noord-Amerika is ieder
jaar toegenomen en was aanzienlijk groter dan het aantal nieuw geworven
donoren in West-Europa (3389 tegen 943 in 1996). Behalve in Oost-Europa,
waar bijna geen niertransplantaties werden uitgevoerd met organen van lev-
ende donoren, is het aantal levende nierdonoren in de andere geografische
regio's sterk gestegen. In Latijns-Amerika van 29% in de jaren 1970-1988 tot
51% in 1995. In Azie werd zelfs 90% van de nieren van levende donoren
verkregen. Omdat de kwaliteit van donororganen uit overledenen vaak niet
optimaal is, zal het gebruik van levende donoren in zowel West-Europa als
Noord-Amerika waarschijnlijkverdertoenemen, maarhetisniette verwachten
dat dit de belangrijkste bron van organen in deze gebieden zal worden.
Een Europese visie op donorwerving
Het wereldwijde tekort aan donororganen heeft geleid tot nationale en inter-
nationale maatregelen om donoren te werven. Deze ontwikkeling wordt
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beschreven in hoofdstuk 6. Genoemde maatregelen bevorderen niet alleen de
donatie van organen, maar waarborgen eveneens een rechtvaardige toewijz-
ing van beschikbare donororganen door een combinatie van wetgeving,
orgaanuitwisselingsorganisaties (OEO's), transplantatie-coördinatoren, pub-
liciteitscampagnes, donorprogramma's en opleidingen voor professionals. De
ontwikkeling van nationale en internationale orgaan-uitwisselingsorganisa-
ties is belangrijk in dit proces, omdat zij wachtlijsten bijhouden en net meest
geschikt zijn om organen toe te wijzen. In de meeste landen zijn ook transplan-
tatiecoördinatoren werkzaam wier taak het is een schakel te vormen tussen
transplantatiecentra en intensive care-afdelingen, protocollen op te stellen
voor orgaandonatie en het ziekenhuispersoneel te helpen omgaan met alle
vertrouwelijke zaken rondom orgaandonatie. Een initiatief op het gebied van
de professionele voorlichting, zoals het door Eurotransplant ontwikkelde
European Donor Hospital Education Programme, wordt nu in 30 landen
wereldwijd gebruikt. Het doel van het programma is om het begrip voor
wettelijke en ethische zaken rondom donatie en transplantatie bij profession-
als te vergroten en om hen te helpen doeltreffender en op een empatische
wijze te communiceren met de nabestaanden van potentiele donoren. Andere
initiatieven omvatten programma's zoals het Donor Action Programme dat
opgezet is door professionele organisaties in de VS en Europa. Dit programma
wil ziekenhuizen helpen een donorwervingsprogramma op maat te maken,
zodat alle potentiele donoren worden herkend en gemeld en de getroffen
familie op een zorgzame en meelevende manier wordt opgevangen.
EDHEP
Bij de medische beroepsgroep bestaat een gebrek aan training en/of ervaring
in de omgang met nabestaanden en het directe verzoek om orgaandonatie.
EDHEP is ontwikkeld om dit probleem aan te pakken. Het programma is vooral
bedoeld om een voor heel Europa geschikt educatief programma op te zetten,
dat het medische personeel bijbrengt hoe zij op een verantwoorde wijze een
diepbedroefd familielid om orgaandonatie kunnen vragen.
De opvallende internationale belangstelling voor EDHEP toont aan, dat er een
grote bezorgdheid bestaat over het tekort aan donororganen en het gebrek
aan communicatie-vaardigheidstrainingen binnen de medische en verpleeg-
kundige opleidingen.
De workshop "vaardigheidsbewustwording" komt tegemoet aan de huidige
behoefte van medewerkers op de kritieke zorgafdeling van ziekenhuizen.
Op de lange termijn beoogt EDHEP dat zij zieh positief opstellen tegenover
orgaantransplantatie. Hierdoor kan het verdriet van de nabestaanden moge-
lijk verlicht worden, waardoor het aantal orgaandonaties zal kunnen toene-
men.
Donor Action
Donor Action (DA) is een intemationaal initiatief dat intensive care-afdelingen
(IC's) in Staat stelt donatie te bevorderen en wordt verder beschreven in
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hoofdstuk 8. De beste procedures uit de hele wereld zijn samengevoegd in dit
kwaliteitsplan. Na een zogenaamde Diagnostic Review van de ziekenhu-
isafdeling worden de zwakke plekken in de donatieprocedure opgespoord en
passende veranderingen voorgesteld. Corrigerende maatregelen zijn on-
twikkeld in de vorm van een programma dat bestaat uit vijf kemmodules, die
corresponderen met de belangrijkste stappen in het donatieproces en die
integraal- afhankelijk van de specifieke situatie- afzonderlijk toegepast kun-
nen worden. Medical Records Review (MRR) en Hospital Attitude Surveys
(HAS) werden uitgevoerd in 11 IC-afdelingen in Spanje (2), Nederland (2),
Groot-Brittannie (1) en Canada (6). Op afdelingen waar potentieel donaties
kunnen voorkomen, werd een aantal basisgegevens verzameld over de
houding van het personeel ten opzichte van donatie en een zelfrapportage
over vaardig-heden/zelfvertrouwen bij het uitvoeren van een aantal taken in
het donatieproces. De analyse van de gegevens werd gebruikt om het
programma aan te passen aan de eisen van afzonderlijke IC-afdelingen.
MRR-gegevens van 579 gevallen toonden aan dat 69% (398) van de over-
ledenen potentieel geschikt was voor donatie; daarvan werd maar 31% (124)
uitgevoerd. Het niet herkennen en uitvoeren (166; 42%) alsmede weigering
van donatie (104; 26%) waren de belangrijkste redenen voor het verloren gaan
van potentiele donoren. Uit de HAS die door het ziekenhuispersoneel werden
teruggestuurd (2129), bleek steeds weer dat men van mening is dat orgaan-
donatie levens redt (97%). Steun aan donatie (94%) en de bereidheid om
eigen organen te doneren (79%) scoorden hoog in alle onderzochte landen.
Percentages voor vaardigheden/zelfvertrouwen waren het hoogst waar het
het opvangen van de familie betrof (70%). Men voelde zieh minder gemakkel-
ijk als het erom ging de hersendood uit te leggen (44%) of te beginnen over
orgaandonatie (38%) resp. de familie te vragen om voor donatie te kiezen
(31%). Na de introduetie van de geschikte programmamodules werd een
verhoogd donatiepercentage van 33% geconstateerd. De Donor Action HAS
en MRR blijken geschikte methoden om problemen in het donatieproces te
achterhalen en resulteren in het doorvoeren van maatregelen en verbeterin-
gen, waardoor het aantal orgaandonaties stijgt.
Toekomstige ontwikkelingen bij de toewijzing van organen
Het voortdurende tekort aan donororganen heeft ertoe geleid dat de beperkin-
gen, die eerder golden voor potentiele donoren moeten worden herzien. Het
is dan ook nodig om voortdurend na te gaan of deze beperkingen nog wel
gegrond zijn. De mogelijkheid van alternatieve strategieen wordt nu onderzo-
cht, zoals het gebruik van "non-heart beating" donoren, minder "goede"
donoren, oudere donoren, enz. Daarnaast worden nieuwe chirurgische tech-
nieken zoals de split-liver techniek en en-bloc transplantaties gei'ntroduceerd.
Het gebruik van nieren van oudere donoren werd altijd gezien als een optie die
minder goede resultaten gaf. Er is echter bewezen dat nieren van oudere
donoren, zelfs bij een wat verminderde nierfunctie, goed blijken te functioner-
en bij zowel oudere als jonge patienten. Eurotransplant heeft in reaktie op het
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voortdurende tekort aan orgaandonoren en de veranderde donorkenmerken
besloten om zijn algoritme voor nierallocatie uit te breiden en donoren van 65
jaar of ouder op te nemen in net speciale Eurotransplant Senior Program
(ESP). Voorlopige gegevens van het ESP en gegevens van andere studies
wijzen er op dat de kans groot is dat de resultaten bijzonder goed zullen
uitvallen, vooropgesteld dat de voorwaarden voor transplantatie geoptimali-
seerd worden en de donor en de ontvanger zorgvuldig geselecteerd worden
(zie hoofdstuk 9).
Het opheffen van beperkingen moet echter voorzichtig gebeuren en alleen op
basis van zorgvuldig wetenschappelijk onderzoek. Bijvoorbeeld, het besluit
om nieren te gebruiken van donoren van 65 jaar en ouder zal het aanbod van
donoren weliswaar vergroten, maar kan ook een groter risico betekenen voor
de individuele patienten. De allocatie algoritmen die door de orgaanuitwis-
selingsorganisaties worden gebruikt, moeten daarom regelmatig bijgesteld
worden om met nieuwe ontwikkelingen -zoals het gebruik van minder goede
donororganen- rekening te houden. Als deze algoritmen niet aangepast
worden, zullen organen niet op de meest rechtvaardige manier worden
toegewezen.
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